,docid,isValid,passage,passageid
0,IEPA.d0,True, PROTEIN1 stimulates PROTEIN2 production in dose-dependent fashion as well,IEPA.d0.s0
1,IEPA.d1,True,"Phosphoinositide hydrolysis, resulting in PROTEIN1 (IP3) and diacylglycerol (DG) formation, has been implicated in PROTEIN2 stimulated pulsatile secretion of prostaglandin F2 alpha (PGF2 alpha) from uterine endometrium of sheep and other mammals",IEPA.d1.s1
2,IEPA.d2,False,"SP ewes also had greater incorporation of [3H]inositol into PROTEIN (IP3) (+3449%, p less than 0.01) and total PROTEIN1 (IP) (+760%, p less than 0.08), in response to PROTEIN than did oCSP ewes (+553 and +168% for PROTEIN and total PROTEIN2 respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2
3,IEPA.d2,False,"SP ewes also had greater incorporation of [3H]inositol into PROTEIN1 (IP3) (+3449%, p less than 0.01) and total PROTEIN2 (IP) (+760%, p less than 0.08), in response to PROTEIN than did oCSP ewes (+553 and +168% for PROTEIN and total PROTEIN respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2
4,IEPA.d2,False,"SP ewes also had greater incorporation of [3H]inositol into PROTEIN (IP3) (+3449%, p less than 0.01) and total PROTEIN1 (IP) (+760%, p less than 0.08), in response to PROTEIN than did oCSP ewes (+553 and +168% for PROTEIN2 and total PROTEIN respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2
5,IEPA.d2,True,"SP ewes also had greater incorporation of [3H]inositol into PROTEIN (IP3) (+3449%, p less than 0.01) and total PROTEIN1 (IP) (+760%, p less than 0.08), in response to PROTEIN2 than did oCSP ewes (+553 and +168% for PROTEIN and total PROTEIN respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2
6,IEPA.d2,False,"SP ewes also had greater incorporation of [3H]inositol into PROTEIN1 (IP3) (+3449%, p less than 0.01) and total PROTEIN (IP) (+760%, p less than 0.08), in response to PROTEIN than did oCSP ewes (+553 and +168% for PROTEIN and total PROTEIN2 respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2
7,IEPA.d2,False,"SP ewes also had greater incorporation of [3H]inositol into PROTEIN (IP3) (+3449%, p less than 0.01) and total PROTEIN (IP) (+760%, p less than 0.08), in response to PROTEIN than did oCSP ewes (+553 and +168% for PROTEIN1 and total PROTEIN2 respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2
8,IEPA.d2,True,"SP ewes also had greater incorporation of [3H]inositol into PROTEIN (IP3) (+3449%, p less than 0.01) and total PROTEIN (IP) (+760%, p less than 0.08), in response to PROTEIN1 than did oCSP ewes (+553 and +168% for PROTEIN and total PROTEIN2 respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2
9,IEPA.d2,False,"SP ewes also had greater incorporation of [3H]inositol into PROTEIN1 (IP3) (+3449%, p less than 0.01) and total PROTEIN (IP) (+760%, p less than 0.08), in response to PROTEIN than did oCSP ewes (+553 and +168% for PROTEIN2 and total PROTEIN respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2
10,IEPA.d2,True,"SP ewes also had greater incorporation of [3H]inositol into PROTEIN1 (IP3) (+3449%, p less than 0.01) and total PROTEIN (IP) (+760%, p less than 0.08), in response to PROTEIN2 than did oCSP ewes (+553 and +168% for PROTEIN and total PROTEIN respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2
11,IEPA.d2,True,"SP ewes also had greater incorporation of [3H]inositol into PROTEIN (IP3) (+3449%, p less than 0.01) and total PROTEIN (IP) (+760%, p less than 0.08), in response to PROTEIN1 than did oCSP ewes (+553 and +168% for PROTEIN2 and total PROTEIN respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2
12,IEPA.d2,False,"These results indicate that oTP-1 may prevent luteolysis by inhibiting development of endometrial responsiveness to PROTEIN1 and, therefore, reduce PROTEIN2 induced synthesis of PROTEIN and PGF2 alpha",IEPA.d2.s3
13,IEPA.d2,True,"These results indicate that oTP-1 may prevent luteolysis by inhibiting development of endometrial responsiveness to PROTEIN and, therefore, reduce PROTEIN1 induced synthesis of PROTEIN2 and PGF2 alpha",IEPA.d2.s3
14,IEPA.d2,False,"These results indicate that oTP-1 may prevent luteolysis by inhibiting development of endometrial responsiveness to PROTEIN1 and, therefore, reduce PROTEIN induced synthesis of PROTEIN2 and PGF2 alpha",IEPA.d2.s3
15,IEPA.d3,False, PROTEIN1 and PROTEIN2 binding in human myometrium,IEPA.d3.s4
16,IEPA.d4,False,The effects of prostaglandin F2 alpha (PGF2 alpha) on intracellular Ca2+ concentration ([Ca2+]i) and PROTEIN1 (IP) generation in human myometrial cells were evaluated and compared to the effects of PROTEIN2 ,IEPA.d4.s5
17,IEPA.d4,True,"In contrast, the potencies of PROTEIN1 to raise PROTEIN2 and [Ca2+]i were similar and independent of extracellular Ca2+, and could be suppressed by pertussis toxin and phorbol ester, but not by verapamil",IEPA.d4.s6
18,IEPA.d4,True,"The action of PGF2 alpha depends on extracellular Ca2+, whereas PROTEIN1 activates the G-protein-dependent phospholipase-C- PROTEIN2 Ca2+ signal-transducing pathway, complemented by the influx of extracellular Ca2+",IEPA.d4.s7
19,IEPA.d8,False,"The objectives of this study were to evaluate and compare the actions of endothelin-1 (ET-1), PROTEIN1 prostaglandin F2 alpha (PGF2 alpha) and PROTEIN2 (IP3) on 45Ca2+ mobilization in permeabilized rat myometrial cells and to examine the activation of the inositol lipid cycle in intact myocytes",IEPA.d8.s14
20,IEPA.d8,False,"All four agonists caused a biphasic release of 45Ca2+ from non-mitochondrial pool(s), with the rank order of potency: PROTEIN1 > PGF2 alpha > ET-1 > PROTEIN2 ",IEPA.d8.s15
21,IEPA.d8,True,"Endothelin-1 and PROTEIN1 stimulated PROTEIN2 accumulation at concentrations similar to those that promoted 45Ca2+ efflux, whereas about 100 times higher concentrations of PGF2 alpha were needed to activate this signaling pathway in intact cells",IEPA.d8.s16
22,IEPA.d8,True,"It is concluded that the primary action of PGF2 alpha in myometrial cells is to enhance Ca2+ influx, whereas PROTEIN1 and ET-1 receptors are coupled to phospholipase C, generating PROTEIN2 and raising the intracellular concentration of free Ca2+ from intracellular as well as extracellular sources",IEPA.d8.s17
23,IEPA.d9,False," PROTEIN1 induced a biphasic increase in the intracellular Ca2+ concentration of porcine myometrial cells: participation of a pertussis toxin-insensitive G-protein, PROTEIN2 sensitive Ca2+ pool, and Ca2+ channels",IEPA.d9.s18
24,IEPA.d9,True,Administration of PROTEIN1 (1 microM) for 15 sec increased PROTEIN2 (IP3) formation by 61%,IEPA.d9.s19
25,IEPA.d9,True,"Pretreatment with pertussis toxin (PTX, 1 microgram/ml) for 2 hr failed to alter the PROTEIN1 induced increase in [Ca2+]i and PROTEIN2 formation",IEPA.d9.s20
26,IEPA.d9,True,U-73122 (3 microM) also abolished the PROTEIN1 induced PROTEIN2 formation,IEPA.d9.s21
27,IEPA.d10,True, PROTEIN1 beta protein disruption of cholinergic and growth factor PROTEIN2 signals could underlie cognitive and neurodegerative aspects of Alzheimer's disease,IEPA.d10.s22
28,IEPA.d11,True," PROTEIN1 beta protein (25-35) stimulation of PROTEIN2 A, C and D activities of LA-N-2 cells",IEPA.d11.s23
29,IEPA.d11,False,"[3H]Inositol prelabeled LA-N-2 cells were exposed to varying concentrations of PROTEIN1 from 20 to 125 micrograms/ml, and PROTEIN2 activation was measured",IEPA.d11.s24
30,IEPA.d11,True,"The effects of adrenergic, metabotropic amino acid and bombesin antagonists on the PROTEIN1 mediated stimulation of PROTEIN2 activity was investigated",IEPA.d11.s25
31,IEPA.d11,True,"Propranolol, a beta adrenergic antagonist, 7-chloro-kynurenic acid, a metabotropic amino acid antagonist, and [Tyr4-D-Phe12]bombesin, a bombesin antagonist, blunted the PROTEIN1 stimulation of PROTEIN2 activity in [3H]inositol prelabeled LA-N-2 cells",IEPA.d11.s26
32,IEPA.d11,True,This suggests that PROTEIN1 beta protein activation of PROTEIN2 may be receptor mediated,IEPA.d11.s27
33,IEPA.d11,False,The PROTEIN1 inhibitor U 71322 prevented the activation of PROTEIN by PROTEIN2 ,IEPA.d11.s28
34,IEPA.d11,True,The PROTEIN inhibitor U 71322 prevented the activation of PROTEIN1 by PROTEIN2 ,IEPA.d11.s28
35,IEPA.d11,False,The PROTEIN1 inhibitor U 71322 prevented the activation of PROTEIN2 by PROTEIN ,IEPA.d11.s28
36,IEPA.d12,True,These results suggest that PROTEIN1 secretion and PROTEIN production in NT2N neurons are regulated by the muscarinic/ PROTEIN2 signal transduction pathway,IEPA.d12.s29
37,IEPA.d12,True,These results suggest that PROTEIN secretion and PROTEIN1 production in NT2N neurons are regulated by the muscarinic/ PROTEIN2 signal transduction pathway,IEPA.d12.s29
38,IEPA.d12,False,These results suggest that PROTEIN1 secretion and PROTEIN2 production in NT2N neurons are regulated by the muscarinic/ PROTEIN signal transduction pathway,IEPA.d12.s29
39,IEPA.d13,False,"Current interest in reducing heart disease risks by diet involves attention to total fat; saturated, monounsaturated, polyunsaturated and trans fatty acids, as well as dietary PROTEIN1 soluble fiber, salt, alcohol, antioxidants, dietary alterations causing homocysteinemia and other dietary constituents, such as PROTEIN2 compounds in some soy products",IEPA.d13.s30
40,IEPA.d14,False,This indicates that the calcium response to PROTEIN1 application was principally associated with activation of the PROTEIN2 sensitive calcium stores,IEPA.d14.s31
41,IEPA.d15,True,The beta PROTEIN1 protein fragments had diverse effects on phosphoinositide-specific PROTEIN2 (PI-PLC) as assayed in rat cortical membranes,IEPA.d15.s32
42,IEPA.d16,False,"They are needed for the catabolism of PROTEIN1 bile acids, and steroid hormones; they hydrolyze a number of PROTEIN2 glycosides to anticarcinogens; and they detoxify certain carcinogens",IEPA.d16.s33
43,IEPA.d17,False,"The aim of this study was to investigate the effects of hCG, hCG plus PROTEIN1 and PROTEIN2 on [3H] PROTEIN (IP) formations in porcine myometrial cells obtained from ovariectomized and cyclic gilts",IEPA.d17.s34
44,IEPA.d17,True,"The aim of this study was to investigate the effects of hCG, hCG plus PROTEIN and PROTEIN1 on [3H] PROTEIN2 (IP) formations in porcine myometrial cells obtained from ovariectomized and cyclic gilts",IEPA.d17.s34
45,IEPA.d17,True,"The aim of this study was to investigate the effects of hCG, hCG plus PROTEIN1 and PROTEIN on [3H] PROTEIN2 (IP) formations in porcine myometrial cells obtained from ovariectomized and cyclic gilts",IEPA.d17.s34
46,IEPA.d17,True,"The highest production of total PROTEIN1 (d.p.m.) was found in cells from ovariectomized gilts given in vivo estradiol benzoate and progesterone for five consecutive days and treated with 1000 mU hCG and 100 mU hCG plus 1 microM PROTEIN2 (984 +/- 84 and 1063 +/- 131 vs 314 +/- 36, respectively)",IEPA.d17.s35
47,IEPA.d17,False,"There was also a very significant increase of PROTEIN1 after the addition of 1000 mU hCG (p < 0.001) and PROTEIN2 and PROTEIN when 1000 mU hCG plus PROTEIN were added (p < 0.001 and p < 0.01, respectively)",IEPA.d17.s36
48,IEPA.d17,False,"There was also a very significant increase of PROTEIN after the addition of 1000 mU hCG (p < 0.001) and PROTEIN1 and PROTEIN2 when 1000 mU hCG plus PROTEIN were added (p < 0.001 and p < 0.01, respectively)",IEPA.d17.s36
49,IEPA.d17,True,"There was also a very significant increase of PROTEIN after the addition of 1000 mU hCG (p < 0.001) and PROTEIN1 and PROTEIN when 1000 mU hCG plus PROTEIN2 were added (p < 0.001 and p < 0.01, respectively)",IEPA.d17.s36
50,IEPA.d17,False,"There was also a very significant increase of PROTEIN1 after the addition of 1000 mU hCG (p < 0.001) and PROTEIN and PROTEIN2 when 1000 mU hCG plus PROTEIN were added (p < 0.001 and p < 0.01, respectively)",IEPA.d17.s36
51,IEPA.d17,True,"There was also a very significant increase of PROTEIN1 after the addition of 1000 mU hCG (p < 0.001) and PROTEIN and PROTEIN when 1000 mU hCG plus PROTEIN2 were added (p < 0.001 and p < 0.01, respectively)",IEPA.d17.s36
52,IEPA.d17,True,"There was also a very significant increase of PROTEIN after the addition of 1000 mU hCG (p < 0.001) and PROTEIN and PROTEIN1 when 1000 mU hCG plus PROTEIN2 were added (p < 0.001 and p < 0.01, respectively)",IEPA.d17.s36
53,IEPA.d17,True,Only PROTEIN1 alone increased the formation of PROTEIN2 in cells from ovariectomized pigs treated with estradiol in vivo (p < 0.01),IEPA.d17.s37
54,IEPA.d17,True,The highest dose of hCG plus The highest dose of hCG plus PROTEIN1 provoked accumulation of total [3H] PROTEIN2 (p < 0.05) 53% over the basal level on days 21/1 of the estrous cycle,IEPA.d17.s38
55,IEPA.d17,True,The present study demonstrates that hCG and PROTEIN1 can increase the accumulation of PROTEIN2 in porcine myometrial cells,IEPA.d17.s39
56,IEPA.d18,False,"The relative risks between highest and lowest quarters of PROTEIN1 intake adjusted for age, smoking, serum PROTEIN2 concentration, blood pressure, and body mass index were 0.69 (95% confidence interval 0.53 to 0.90) and 0.54 (0.33 to 0.87) for total and coronary mortality, respectively",IEPA.d18.s40
57,IEPA.d19,False,"Granulosa cells were isolated from bovine preovulatory follicles and cultured for 3 days with or without PROTEIN1 in medium supplemented with either PROTEIN2 (1 microgram/ml) + 1% fetal calf serum (FCS), which maintains basal estradiol secretion, or low doses of FSH (1 and 2 ng/ml) + 1% FCS, a culture condition that maximizes effects of FSH on estradiol secretion",IEPA.d19.s41
58,IEPA.d20,True,"We propose that PROTEIN1 binds to specific OT receptors (OTR) on the endometrium to stimulate phosphoinositide (PI) hydrolysis, thereby activating the inositol trisphosphate ( PROTEIN2 -diacylglycerol (DAG) second-messenger system to promote pulsatile PGF2 alpha secretion",IEPA.d20.s42
59,IEPA.d20,True,Endometrial PROTEIN1 was increased within 30 seconds after PROTEIN2 treatment and preceded the increase in PGF2 alpha release stimulated by PROTEIN ,IEPA.d20.s43
60,IEPA.d20,False,Endometrial PROTEIN was increased within 30 seconds after PROTEIN1 treatment and preceded the increase in PGF2 alpha release stimulated by PROTEIN2 ,IEPA.d20.s43
61,IEPA.d20,False,Endometrial PROTEIN1 was increased within 30 seconds after PROTEIN treatment and preceded the increase in PGF2 alpha release stimulated by PROTEIN2 ,IEPA.d20.s43
62,IEPA.d20,True,"These results support the hypothesis that PROTEIN1 stimulates phospholipase C to hydrolyze PI, yielding PROTEIN2 and DAG second-messengers which promote endometrial PGF2 alpha release during CL regression in pigs",IEPA.d20.s44
63,IEPA.d21,True,These data suggest that cAMP-dependent phosphorylation at a step involving GTP-binding protein/PLC coupling can exert a negative effect on the stimulation of PROTEIN1 formation by PROTEIN2 and thereby affect contraction/relaxation in the myometrium,IEPA.d21.s45
64,IEPA.d22,False,"Once the abnormally phosphorylated abnormal PROTEIN1 isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular PROTEIN isoform that aggregates to abnormally phosphorylated abnormal PROTEIN isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a PROTEIN2 specific PROTEIN ",IEPA.d22.s46
65,IEPA.d22,False,"Once the abnormally phosphorylated abnormal PROTEIN isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular PROTEIN1 isoform that aggregates to abnormally phosphorylated abnormal PROTEIN isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a PROTEIN2 specific PROTEIN ",IEPA.d22.s46
66,IEPA.d22,False,"Once the abnormally phosphorylated abnormal PROTEIN isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular PROTEIN isoform that aggregates to abnormally phosphorylated abnormal PROTEIN1 isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a PROTEIN2 specific PROTEIN ",IEPA.d22.s46
67,IEPA.d22,True,"Once the abnormally phosphorylated abnormal PROTEIN isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular PROTEIN isoform that aggregates to abnormally phosphorylated abnormal PROTEIN isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a PROTEIN1 specific PROTEIN2 ",IEPA.d22.s46
68,IEPA.d22,False,"Once the abnormally phosphorylated abnormal PROTEIN1 isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular PROTEIN2 isoform that aggregates to abnormally phosphorylated abnormal PROTEIN isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a PROTEIN specific PROTEIN ",IEPA.d22.s46
69,IEPA.d22,False,"Once the abnormally phosphorylated abnormal PROTEIN1 isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular PROTEIN isoform that aggregates to abnormally phosphorylated abnormal PROTEIN2 isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a PROTEIN specific PROTEIN ",IEPA.d22.s46
70,IEPA.d22,False,"Once the abnormally phosphorylated abnormal PROTEIN1 isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular PROTEIN isoform that aggregates to abnormally phosphorylated abnormal PROTEIN isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a PROTEIN specific PROTEIN2 ",IEPA.d22.s46
71,IEPA.d22,False,"Once the abnormally phosphorylated abnormal PROTEIN isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular PROTEIN1 isoform that aggregates to abnormally phosphorylated abnormal PROTEIN2 isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a PROTEIN specific PROTEIN ",IEPA.d22.s46
72,IEPA.d22,False,"Once the abnormally phosphorylated abnormal PROTEIN isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular PROTEIN1 isoform that aggregates to abnormally phosphorylated abnormal PROTEIN isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a PROTEIN specific PROTEIN2 ",IEPA.d22.s46
73,IEPA.d22,False,"Once the abnormally phosphorylated abnormal PROTEIN isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular PROTEIN isoform that aggregates to abnormally phosphorylated abnormal PROTEIN1 isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a PROTEIN specific PROTEIN2 ",IEPA.d22.s46
74,IEPA.d23,True,The resulting abnormally phosphorylated PROTEIN aggregates to freshly synthesized PROTEIN transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a PROTEIN1 specific PROTEIN2 ,IEPA.d23.s47
75,IEPA.d23,False,The resulting abnormally phosphorylated PROTEIN aggregates to freshly synthesized PROTEIN1 transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a PROTEIN specific PROTEIN2 ,IEPA.d23.s47
76,IEPA.d23,False,The resulting abnormally phosphorylated PROTEIN1 aggregates to freshly synthesized PROTEIN transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a PROTEIN specific PROTEIN2 ,IEPA.d23.s47
77,IEPA.d23,False,The resulting abnormally phosphorylated PROTEIN aggregates to freshly synthesized PROTEIN1 transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a PROTEIN2 specific PROTEIN ,IEPA.d23.s47
78,IEPA.d23,False,The resulting abnormally phosphorylated PROTEIN1 aggregates to freshly synthesized PROTEIN transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a PROTEIN2 specific PROTEIN ,IEPA.d23.s47
79,IEPA.d23,False,The resulting abnormally phosphorylated PROTEIN1 aggregates to freshly synthesized PROTEIN2 transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a PROTEIN specific PROTEIN ,IEPA.d23.s47
80,IEPA.d24,True,The aim of the present study was to investigate how PROTEIN1 given subcutaneously (SC) and intracerebroventricularly (ICV) influences the secretion of PROTEIN2 glucagon and glucose and to investigate whether the effect on these variables of suckling in lactating rats is mediated by oxytocinergic mechanisms,IEPA.d24.s48
81,IEPA.d24,True,Subcutaneous injections of PROTEIN1 increased PROTEIN2 glucagon and glucose levels significantly,IEPA.d24.s49
82,IEPA.d24,True,Two nanograms PROTEIN1 given ICV had no effect on glucagon and glucose levels but caused a significant rise in PROTEIN2 levels at this time point,IEPA.d24.s50
83,IEPA.d24,False,The PROTEIN1 antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased PROTEIN2 levels itself and therefore the effect on PROTEIN induced PROTEIN secretion was difficult to evaluate,IEPA.d24.s51
84,IEPA.d24,False,The PROTEIN1 antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased PROTEIN levels itself and therefore the effect on PROTEIN induced PROTEIN2 secretion was difficult to evaluate,IEPA.d24.s51
85,IEPA.d24,False,The PROTEIN1 antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased PROTEIN levels itself and therefore the effect on PROTEIN2 induced PROTEIN secretion was difficult to evaluate,IEPA.d24.s51
86,IEPA.d24,False,The PROTEIN antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased PROTEIN1 levels itself and therefore the effect on PROTEIN induced PROTEIN2 secretion was difficult to evaluate,IEPA.d24.s51
87,IEPA.d24,False,The PROTEIN antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased PROTEIN1 levels itself and therefore the effect on PROTEIN2 induced PROTEIN secretion was difficult to evaluate,IEPA.d24.s51
88,IEPA.d24,True,The PROTEIN antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased PROTEIN levels itself and therefore the effect on PROTEIN1 induced PROTEIN2 secretion was difficult to evaluate,IEPA.d24.s51
89,IEPA.d24,True,Intracerebroventricular injections of 200 ng PROTEIN1 caused a significant rise not only of PROTEIN2 but also of glucagon and glucose levels,IEPA.d24.s52
90,IEPA.d24,True,"In contrast, nanogram amounts of PROTEIN1 administered ICV cause a rise of PROTEIN2 levels",IEPA.d24.s53
91,IEPA.d25,False,The responses of serum PROTEIN1 (OT) and vasopressin (AVP) to the serotonergic HT1A agonist buspirone (15 mg p.o.) or the HTD1 agonist sumatriptan (6 mg injected subcutaneously) were evaluated in 7 normal men either in basal conditions or during an PROTEIN2 (0.15 iu/kg as an i.v. bolus) tolerance test (ITT),IEPA.d25.s54
92,IEPA.d25,True,Stimulation of 5HT-1D receptors with sumatriptan was unable to change neither AVP nor PROTEIN1 response to PROTEIN2 induced hypoglycemia,IEPA.d25.s55
93,IEPA.d26,False,"The SGR and RGR also had different endocrine profiles with, for example, twice as high PROTEIN1 (p < 0.01) and PROTEIN2 levels (p < 0.01) in RGR compared to the SGR",IEPA.d26.s56
94,IEPA.d27,True,"8-OH-DPAT also increased PROTEIN1 and decreased CCK and somatostatin levels, effects that were blocked by pretreatment with the PROTEIN2 antagonist",IEPA.d27.s57
95,IEPA.d27,True,"Taken together, these data suggest that the effect of 8-OH-DPAT on plasma levels of PROTEIN1 somatostatin and CCK may be mediated by PROTEIN2 ",IEPA.d27.s58
96,IEPA.d27,True,"In previous experiments, we have shown that following i.c.v. application of PROTEIN1 plasma levels of PROTEIN2 are increased through a cholinergic mechanism",IEPA.d27.s59
97,IEPA.d28,False,"In HVSMC both PROTEIN1 and AVP increased PROTEIN (IP3) production and [Ca2+]i response, but the efficacy of the responses was greater for PROTEIN2 than AVP",IEPA.d28.s60
98,IEPA.d28,True,"In HVSMC both PROTEIN1 and AVP increased PROTEIN2 (IP3) production and [Ca2+]i response, but the efficacy of the responses was greater for PROTEIN than AVP",IEPA.d28.s60
99,IEPA.d28,False,"In HVSMC both PROTEIN and AVP increased PROTEIN1 (IP3) production and [Ca2+]i response, but the efficacy of the responses was greater for PROTEIN2 than AVP",IEPA.d28.s60
100,IEPA.d31,True," PROTEIN1 may rapidly stimulate PROTEIN2 (IP3) and diacylglycerol (DAG) formation, consistent with the concept of rapid activation of a second-messenger system",IEPA.d31.s63
101,IEPA.d31,True,"In support of this hypothesis, endometrial PROTEIN1 levels were increased (P < 0.05) within 0.5 min after treatment with 0.1 microM PROTEIN2 ",IEPA.d31.s64
102,IEPA.d31,True,These results indicate that PROTEIN1 induces endometrial PROTEIN2 production in a rapid manner indicative of a second-messenger system,IEPA.d31.s65
103,IEPA.d32,True,Gamma-aminobutyric acid mediation of the inhibitory effect of nitric oxide on the arginine vasopressin and PROTEIN1 responses to PROTEIN2 induced hypoglycemia,IEPA.d32.s66
104,IEPA.d32,True,"Previous studies have demonstrated that the nitric oxide (NO) synthase inhibitor L-NAME exerts positive effects on the arginine vasopressin (AVP) and PROTEIN1 (OT) responses to PROTEIN2 induced hypoglycemia, suggesting inhibitory actions of NO",IEPA.d32.s67
105,IEPA.d32,False,"AVP and PROTEIN1 secretory patterns during PROTEIN2 (0.15 IU/kg, i.v.)-tolerance tests (ITT) were examined in seven normal male subjects with (experimental tests) and without (control test) concomitant treatment with L-NAME (40 micrograms/kg injected plus 50 micrograms/kg infused, i.v.), the GABAergic agent sodium valproate (600 mg in three divided doses orally) or the combination of L-NAME and sodium valproate",IEPA.d32.s68
106,IEPA.d32,True, PROTEIN1 induced hypoglycemia increased by 2-fold (peak vs. baseline) plasma AVP and PROTEIN2 levels,IEPA.d32.s69
107,IEPA.d32,True,These data indicate a GABAergic mediation of the inhibitory modulation by NO of the AVP and PROTEIN1 responses to PROTEIN2 induced hypoglycemia,IEPA.d32.s70
108,IEPA.d33,True,Correlation between the stimulatory effect of PROTEIN1 on the formation of PROTEIN2 and the oxytocin receptor level in the pregnant rabbit myometrium,IEPA.d33.s71
109,IEPA.d33,False,"OBJECTIVE: In order to elucidate the roles of PROTEIN1 (IP3) and oxytocin (OT) receptors in rabbit parturition, the concentration of PROTEIN2 induced by PROTEIN and the OT receptor levels were determined in rabbit myometria before and after parturition",IEPA.d33.s72
110,IEPA.d33,False,"OBJECTIVE: In order to elucidate the roles of PROTEIN1 (IP3) and oxytocin (OT) receptors in rabbit parturition, the concentration of PROTEIN induced by PROTEIN2 and the OT receptor levels were determined in rabbit myometria before and after parturition",IEPA.d33.s72
111,IEPA.d33,True,"OBJECTIVE: In order to elucidate the roles of PROTEIN (IP3) and oxytocin (OT) receptors in rabbit parturition, the concentration of PROTEIN1 induced by PROTEIN2 and the OT receptor levels were determined in rabbit myometria before and after parturition",IEPA.d33.s72
112,IEPA.d33,False,"METHODS: The effects of PROTEIN1 on PROTEIN2 formation and OT receptor levels were determined in the myometria of non-pregnant rabbits, Days 26, 28 and 30 of pregnancy rabbits, postpartum rabbits within 12 hours and steroid-treated ovariectomized rabbits",IEPA.d33.s73
113,IEPA.d33,True,"RESULTS: OT receptors were not detectable in the myometria of non-pregnant rabbits, and PROTEIN1 had no effect on the formation of PROTEIN2 (IPs)",IEPA.d33.s74
114,IEPA.d33,True,"On Day 28 of pregnancy, OT receptors became detectable, and then PROTEIN1 could induce the formation of PROTEIN2 ",IEPA.d33.s75
115,IEPA.d33,True,"Thereafter, the stimulatory effects of PROTEIN1 on PROTEIN2 formation and the OT receptor levels dramatically increased toward the end of pregnancy and reduced rapidly after parturition",IEPA.d33.s76
116,IEPA.d33,True,"When the ovariectomized pregnant rabbits were treated with estrogen, OT receptors in the myometrium were induced, and PROTEIN1 acquired the ability to stimulate PROTEIN2 formation",IEPA.d33.s77
117,IEPA.d33,True,"In addition, an OT receptor antagonist inhibited the stimulatory effects of PROTEIN1 on PROTEIN2 formation",IEPA.d33.s78
118,IEPA.d33,True,"CONCLUSIONS: These results suggest that the formation of PROTEIN1 by PROTEIN2 the OT receptor levels in the myometrium, and the production of PGF2 in the decidua might play crucial roles in parturition",IEPA.d33.s79
119,IEPA.d34,False,Immunohistochemical localization of PROTEIN1 and PROTEIN2 in white and brown adipose tissue,IEPA.d34.s80
120,IEPA.d34,False,"To establish the cell type expressing PROTEIN1 we also assessed the size and organization of lipid droplets, the ultrastructural features of mitochondria, and the presence or absence of PROTEIN2 a brown fat-specific marker",IEPA.d34.s81
121,IEPA.d34,False,"In brown adipose tissue of lean animals, multilocular PROTEIN1 (UCP)-positive brown adipocytes had typical brown mitochondria and were PROTEIN2 negative, both in fed and fasted conditions",IEPA.d34.s82
122,IEPA.d34,False,"At the periphery of the interscapular brown adipose tissue depot, unilocular, PROTEIN1 negative adipocytes (mean diameter: 41.55 microns) with white-type mitochondria were observed, and these cells were PROTEIN2 positive",IEPA.d34.s83
123,IEPA.d34,False,"In obese (db/db) animals, brown fat was composed mainly of small unilocular, PROTEIN1 positive adipocytes (mean diameter: 40.08 microns), which were also PROTEIN2 positive",IEPA.d34.s84
124,IEPA.d34,False,"In summary, classical brown adipocytes differ from white adipocytes, not only by their morphology and PROTEIN1 expression, but also by their apparent lack of detectable PROTEIN2 expression",IEPA.d34.s85
125,IEPA.d36,False,Wortmannin converts PROTEIN1 but not PROTEIN2 from an antilipolytic to a lipolytic agent in the presence of forskolin,IEPA.d36.s87
126,IEPA.d36,False,"The present studies compared the effects of PROTEIN1 in rat adipocytes with the effects of PROTEIN and peroxovanadate, which mimic some effects of PROTEIN2 ",IEPA.d36.s88
127,IEPA.d36,False,"The present studies compared the effects of PROTEIN1 in rat adipocytes with the effects of PROTEIN2 and peroxovanadate, which mimic some effects of PROTEIN ",IEPA.d36.s88
128,IEPA.d36,False,"The present studies compared the effects of PROTEIN in rat adipocytes with the effects of PROTEIN1 and peroxovanadate, which mimic some effects of PROTEIN2 ",IEPA.d36.s88
129,IEPA.d36,False,"The antilipolytic effects of peroxovanadate and PROTEIN1 were unaffected by 500 nmol/L wortmannin, which blocked the antilipolytic action of PROTEIN2 ",IEPA.d36.s89
130,IEPA.d36,False,The data provide additional support for the hypothesis that PROTEIN1 and peroxovanadate affect adipose tissue metabolism by mechanisms distinctly different from those involved in PROTEIN2 action,IEPA.d36.s90
131,IEPA.d37,False,"These findings support the concept that the mitochondrial metabolism of nutrient molecules is an event sufficient to acutely augment PROTEIN release from the beta cell, to increase PROTEIN1 mediated phosphoinositide hydrolysis, and to induce time-dependent potentiation of PROTEIN2 secretion",IEPA.d37.s91
132,IEPA.d37,False,"These findings support the concept that the mitochondrial metabolism of nutrient molecules is an event sufficient to acutely augment PROTEIN1 release from the beta cell, to increase PROTEIN2 mediated phosphoinositide hydrolysis, and to induce time-dependent potentiation of PROTEIN secretion",IEPA.d37.s91
133,IEPA.d37,False,"These findings support the concept that the mitochondrial metabolism of nutrient molecules is an event sufficient to acutely augment PROTEIN1 release from the beta cell, to increase PROTEIN mediated phosphoinositide hydrolysis, and to induce time-dependent potentiation of PROTEIN2 secretion",IEPA.d37.s91
134,IEPA.d38,False,"2) IGF-1, IGF-2, and PROTEIN1 also induced a Ca2+ mobilization from the endoplasmic reticulum: PROTEIN (PLC) inhibitors, neomycin, or U-73122 partially blocked the intracellular [Ca2+]i increase induced by IGF-1 and PROTEIN2 and totally inhibited the effect of IGF-2",IEPA.d38.s92
135,IEPA.d38,True,"2) IGF-1, IGF-2, and PROTEIN also induced a Ca2+ mobilization from the endoplasmic reticulum: PROTEIN1 (PLC) inhibitors, neomycin, or U-73122 partially blocked the intracellular [Ca2+]i increase induced by IGF-1 and PROTEIN2 and totally inhibited the effect of IGF-2",IEPA.d38.s92
136,IEPA.d38,False,"2) IGF-1, IGF-2, and PROTEIN1 also induced a Ca2+ mobilization from the endoplasmic reticulum: PROTEIN2 (PLC) inhibitors, neomycin, or U-73122 partially blocked the intracellular [Ca2+]i increase induced by IGF-1 and PROTEIN and totally inhibited the effect of IGF-2",IEPA.d38.s92
137,IEPA.d39,False,Homogeneous liposome immunoassay for PROTEIN1 using PROTEIN2 from Clostridium perfringens,IEPA.d39.s93
138,IEPA.d39,False," PROTEIN1 was conjugated to PROTEIN2 by a three-step procedure with hetero-bifunctional crosslinking reagents, succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate and 3-(2-pyridyldithio)propionic acid N-hydroxysuccinimide ester",IEPA.d39.s94
139,IEPA.d39,False,Both p-nitrophenylphosphatidylcholine hydrolytic activity and liposome lytic activity of PROTEIN1 PROTEIN2 conjugate were inhibited in the presence of PROTEIN antiserum,IEPA.d39.s95
140,IEPA.d39,False,Both p-nitrophenylphosphatidylcholine hydrolytic activity and liposome lytic activity of PROTEIN PROTEIN1 conjugate were inhibited in the presence of PROTEIN2 antiserum,IEPA.d39.s95
141,IEPA.d39,False,Both p-nitrophenylphosphatidylcholine hydrolytic activity and liposome lytic activity of PROTEIN1 PROTEIN conjugate were inhibited in the presence of PROTEIN2 antiserum,IEPA.d39.s95
142,IEPA.d40,False,Roles of GTP and PROTEIN1 in the potentiation of Ca(2+)-induced PROTEIN2 secretion by glucose in rat pancreatic islets,IEPA.d40.s96
143,IEPA.d40,False,"There was a 98% greater augmentation of PROTEIN1 secretion by 16.7 mM glucose (in the presence of diazoxide and 40 mM K+) in primed islets; however, the ability of high glucose to augment PROTEIN2 activity bore no relationship to the secretory response",IEPA.d40.s97
144,IEPA.d40,False,"MPA markedly inhibited PROTEIN1 in both conditions; however, PROTEIN2 secretion was only inhibited (by 46%) in primed islets",IEPA.d40.s98
145,IEPA.d40,False,These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced PROTEIN1 secretion in primed islets but that PROTEIN activation can clearly be dissociated from PROTEIN2 secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced PROTEIN secretion,IEPA.d40.s99
146,IEPA.d40,False,These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced PROTEIN secretion in primed islets but that PROTEIN1 activation can clearly be dissociated from PROTEIN2 secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced PROTEIN secretion,IEPA.d40.s99
147,IEPA.d40,False,These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced PROTEIN secretion in primed islets but that PROTEIN activation can clearly be dissociated from PROTEIN1 secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced PROTEIN2 secretion,IEPA.d40.s99
148,IEPA.d40,False,These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced PROTEIN1 secretion in primed islets but that PROTEIN2 activation can clearly be dissociated from PROTEIN secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced PROTEIN secretion,IEPA.d40.s99
149,IEPA.d40,False,These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced PROTEIN1 secretion in primed islets but that PROTEIN activation can clearly be dissociated from PROTEIN secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced PROTEIN2 secretion,IEPA.d40.s99
150,IEPA.d40,False,These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced PROTEIN secretion in primed islets but that PROTEIN1 activation can clearly be dissociated from PROTEIN secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced PROTEIN2 secretion,IEPA.d40.s99
151,IEPA.d41,True,Regulation of PROTEIN1 secretion via ATP-sensitive K+ channel independent mechanisms: role of PROTEIN2 ,IEPA.d41.s100
152,IEPA.d41,True,"The further addition of carbachol, an agonist that activates an isozyme of PROTEIN1 distinct from that activated by glucose, together with K+, 20 mM glucose, plus diazoxide resulted in a sustained amplification of PROTEIN2 secretion from mouse but not rat islets",IEPA.d41.s101
153,IEPA.d41,True,"The inability to activate a nutrient- and calcium-regulated PROTEIN1 isozyme in mouse islets to the same extent as in rat islets appears to account, at least in part, for these different PROTEIN2 secretory responses under these unique conditions",IEPA.d41.s102
154,IEPA.d43,True,Induction by PROTEIN1 of PROTEIN2 and enzymes of fatty acid oxidation,IEPA.d43.s108
155,IEPA.d43,True,Here we show that PROTEIN1 alters in pancreatic islets the mRNA of the genes encoding enzymes of free fatty acid metabolism and PROTEIN2 (UCP-2),IEPA.d43.s109
156,IEPA.d43,True," PROTEIN1 overexpression increased PROTEIN2 mRNA by more than 10-fold in epididymal, retroperitoneal, and subcutaneous fat tissue of normal, but not of leptin-receptor-defective obese rats",IEPA.d43.s110
157,IEPA.d43,True,"By directly regulating the expression of enzymes of free fatty acid metabolism and of PROTEIN1 PROTEIN2 controls intracellular triglyceride content of certain nonadipocytes, as well as adipocytes",IEPA.d43.s111
158,IEPA.d44,False,"Further, the PROTEIN1 induced activation of IK(sl) was effectively antagonized by 5 x 10(-8) mol/l U-73122 or 5 x 10(-6) mol/l 2-nitro-4-carboxyphenyl N,N-diphenylcarbamate (inhibitors of the cell membrane phospholipase C), as well as by intracellularly applied heparin (selective inhibitor of PROTEIN2 (IP3)-induced Ca2+ release channels)",IEPA.d44.s112
159,IEPA.d44,False,"The data obtained suggest (i) that selective PROTEIN1 receptors are present on the membranes of guinea-pig antral smooth muscle cells, (ii) that the oxytocin-related relaxation may result from the activation of Ca(2+)-sensitive K+ conductivity via activation of PROTEIN2 induced release of Ca2+ from the submembrane located cisternae of the sarcoplasmic reticulum Ca2+ stores and (iii) in turn, this evokes a non-inactivating component of IK, hyperpolarizing the cell membrane",IEPA.d44.s113
160,IEPA.d45,False,"Cellular preincubation with 200 microg/ml antibodies against the inositolphosphoglycan (IPG) moiety of the GPI-anchor (Ab(IPG)), or depletion in GPI-anchored proteins by cellular pretreatment with 0.5 U/ml PI- PROTEIN1 1 mM PROTEIN2 and 2 HU/ml streptolysin-O, or depletion in membrane cholesterol content by filipin (5 microg/ml), digitonin (5 microg/ml) and cholesterol oxidase (0.5 U/ml) decreases the HDL3-signal, suggesting the involvement of a lipolytic cleavage of GPI-anchored proteins",IEPA.d45.s114
161,IEPA.d48,True, PROTEIN1 increases PROTEIN2 expression and energy expenditure,IEPA.d48.s123
162,IEPA.d48,True, PROTEIN1 increased BAT PROTEIN2 mRNA levels greater than twofold in both ad libitum-fed and food-restricted rats,IEPA.d48.s124
163,IEPA.d48,False,"These data demonstrate a PROTEIN1 induced increase in energy expenditure in nonmutant rodents and suggest that one mechanism by which PROTEIN increases energy expenditure is through increased thermogenesis in BAT, including increased expression of PROTEIN2 ",IEPA.d48.s125
164,IEPA.d48,False,"These data demonstrate a PROTEIN1 induced increase in energy expenditure in nonmutant rodents and suggest that one mechanism by which PROTEIN2 increases energy expenditure is through increased thermogenesis in BAT, including increased expression of PROTEIN ",IEPA.d48.s125
165,IEPA.d48,True,"These data demonstrate a PROTEIN induced increase in energy expenditure in nonmutant rodents and suggest that one mechanism by which PROTEIN1 increases energy expenditure is through increased thermogenesis in BAT, including increased expression of PROTEIN2 ",IEPA.d48.s125
166,IEPA.d52,True," PROTEIN1 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and PROTEIN2 ",IEPA.d52.s135
167,IEPA.d52,True," PROTEIN1 mRNA levels were also regulated by dexamethasone, PROTEIN2 and starvation, albeit differently in muscle and brown adipose tissue",IEPA.d52.s136
168,IEPA.d54,False,"This effect is maximal at 10(-8) M PROTEIN (a concentration clearly above the normal physiological range of PROTEIN1 concentrations) and involves the V2 receptor pathway, while activation of PROTEIN2 or changes in intracellular calcium are ineffective",IEPA.d54.s138
169,IEPA.d54,False,"This effect is maximal at 10(-8) M PROTEIN1 (a concentration clearly above the normal physiological range of PROTEIN2 concentrations) and involves the V2 receptor pathway, while activation of PROTEIN or changes in intracellular calcium are ineffective",IEPA.d54.s138
170,IEPA.d54,False,"This effect is maximal at 10(-8) M PROTEIN1 (a concentration clearly above the normal physiological range of PROTEIN concentrations) and involves the V2 receptor pathway, while activation of PROTEIN2 or changes in intracellular calcium are ineffective",IEPA.d54.s138
171,IEPA.d55,False,"After PROTEIN1 activity was functionally depleted by treating cells with phorbol 12-myristate 13-acetate for 24 hours, PROTEIN2 did not augment IL-1beta-induced NO production",IEPA.d55.s139
172,IEPA.d55,True,The effect of PROTEIN1 was also inhibited in the presence of the PROTEIN2 inhibitor calphostin C,IEPA.d55.s140
173,IEPA.d55,True,"The addition of PROTEIN1 increased PROTEIN2 activity in cardiac myocytes, and its effect was significantly inhibited in the presence of calphostin C",IEPA.d55.s141
174,IEPA.d55,True,"These results support the hypothesis that the heart may be a target organ for PROTEIN and that PROTEIN1 modulates IL-1beta-induced iNOS expression in myocytes through the V1a receptor, which is mediated at least partially via activation of PROTEIN2 ",IEPA.d55.s142
175,IEPA.d55,False,"These results support the hypothesis that the heart may be a target organ for PROTEIN1 and that PROTEIN2 modulates IL-1beta-induced iNOS expression in myocytes through the V1a receptor, which is mediated at least partially via activation of PROTEIN ",IEPA.d55.s142
176,IEPA.d55,False,"These results support the hypothesis that the heart may be a target organ for PROTEIN1 and that PROTEIN modulates IL-1beta-induced iNOS expression in myocytes through the V1a receptor, which is mediated at least partially via activation of PROTEIN2 ",IEPA.d55.s142
177,IEPA.d57,True,Activation of EGFR overexpressing 3T3-L1 adipocytes leads to a 3.4 +/- 1.2-fold stimulation of PROTEIN1 activity over basal levels vs. only 1.06 +/- 0.01-fold stimulation by PROTEIN2 ,IEPA.d57.s146
178,IEPA.d57,True,"Despite the low levels of PROTEIN1 induced PROTEIN2 activity, PROTEIN stimulated glucose transport activity was similarly inhibited by U73122 (55.9 +/- 13.1% inhibition)",IEPA.d57.s147
179,IEPA.d57,False,"Despite the low levels of PROTEIN1 induced PROTEIN activity, PROTEIN2 stimulated glucose transport activity was similarly inhibited by U73122 (55.9 +/- 13.1% inhibition)",IEPA.d57.s147
180,IEPA.d57,False,"Despite the low levels of PROTEIN induced PROTEIN1 activity, PROTEIN2 stimulated glucose transport activity was similarly inhibited by U73122 (55.9 +/- 13.1% inhibition)",IEPA.d57.s147
181,IEPA.d57,False,"Inhibition of PROTEIN1 activation did not impair either EGF- or PROTEIN2 induced activation of glycogen synthase or incorporation of glucose into lipid, supporting the hypothesis that both EGF- and PROTEIN induced glucose disposal can be independent of GLUT4-mediated glucose transport.",IEPA.d57.s148
182,IEPA.d57,False,"Inhibition of PROTEIN1 activation did not impair either EGF- or PROTEIN induced activation of glycogen synthase or incorporation of glucose into lipid, supporting the hypothesis that both EGF- and PROTEIN2 induced glucose disposal can be independent of GLUT4-mediated glucose transport.",IEPA.d57.s148
183,IEPA.d57,False,"Inhibition of PROTEIN activation did not impair either EGF- or PROTEIN1 induced activation of glycogen synthase or incorporation of glucose into lipid, supporting the hypothesis that both EGF- and PROTEIN2 induced glucose disposal can be independent of GLUT4-mediated glucose transport.",IEPA.d57.s148
184,IEPA.d57,False,The diminution of glucose transport secondary to inhibition of PROTEIN1 activity was reflected by a decrease in GLUT4 translocation to the plasma membrane upon either EGF or PROTEIN2 stimulation,IEPA.d57.s149
185,IEPA.d58,True,We have recently shown that PROTEIN1 causes a PROTEIN2 (PKC)-dependent increase in ACTH release and biosynthesis in ovine anterior pituitary cells,IEPA.d58.s150
186,IEPA.d58,False,"In these cells, PROTEIN also causes the translocation of PROTEIN1 from the cytosol to the cell membrane which is maximal at 5 min, but the intracellular events distal to PROTEIN2 activation that underlie ACTH secretion have not been well characterized to date",IEPA.d58.s151
187,IEPA.d58,False,"In these cells, PROTEIN1 also causes the translocation of PROTEIN from the cytosol to the cell membrane which is maximal at 5 min, but the intracellular events distal to PROTEIN2 activation that underlie ACTH secretion have not been well characterized to date",IEPA.d58.s151
188,IEPA.d58,True,"In these cells, PROTEIN1 also causes the translocation of PROTEIN2 from the cytosol to the cell membrane which is maximal at 5 min, but the intracellular events distal to PROTEIN activation that underlie ACTH secretion have not been well characterized to date",IEPA.d58.s151
189,IEPA.d58,False,"Since the MARCKS protein has been implicated in neurosecretion and is phosphorylated by PROTEIN in synaptosomes, studies were carried out to determine whether PROTEIN1 might cause MARCKS phosphorylation in the ovine anterior pituitary, and to determine whether this phenomenon might be temporally correlated with PROTEIN2 translocation and the release of ACTH",IEPA.d58.s152
190,IEPA.d58,False,"Since the MARCKS protein has been implicated in neurosecretion and is phosphorylated by PROTEIN1 in synaptosomes, studies were carried out to determine whether PROTEIN might cause MARCKS phosphorylation in the ovine anterior pituitary, and to determine whether this phenomenon might be temporally correlated with PROTEIN2 translocation and the release of ACTH",IEPA.d58.s152
191,IEPA.d58,False,"Since the MARCKS protein has been implicated in neurosecretion and is phosphorylated by PROTEIN1 in synaptosomes, studies were carried out to determine whether PROTEIN2 might cause MARCKS phosphorylation in the ovine anterior pituitary, and to determine whether this phenomenon might be temporally correlated with PROTEIN translocation and the release of ACTH",IEPA.d58.s152
192,IEPA.d58,False,"We conclude that: (1) PROTEIN causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the PROTEIN1 induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PROTEIN trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PROTEIN2 activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.",IEPA.d58.s153
193,IEPA.d58,False,"We conclude that: (1) PROTEIN1 causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the PROTEIN induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PROTEIN trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PROTEIN2 activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.",IEPA.d58.s153
194,IEPA.d58,False,"We conclude that: (1) PROTEIN causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the PROTEIN induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PROTEIN1 trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PROTEIN2 activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.",IEPA.d58.s153
195,IEPA.d58,False,"We conclude that: (1) PROTEIN1 causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the PROTEIN2 induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PROTEIN trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PROTEIN activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.",IEPA.d58.s153
196,IEPA.d58,False,"We conclude that: (1) PROTEIN causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the PROTEIN1 induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PROTEIN2 trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PROTEIN activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.",IEPA.d58.s153
197,IEPA.d58,False,"We conclude that: (1) PROTEIN1 causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the PROTEIN induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PROTEIN2 trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PROTEIN activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.",IEPA.d58.s153
198,IEPA.d60,True,"The activity of the MAPKs, induced by PROTEIN1 or PMA was inhibited by downregulation of PROTEIN2 (PKC), by the tyrosine kinase inhibitor genistein and by MAPK kinase (MEK) inhibitor, PD98059",IEPA.d60.s155
199,IEPA.d60,True,"We suggest that PROTEIN1 activates the 42/44kDa MAPKs through a signal transduction pathway that involves stimulation of AVP-V1 receptor, tyrosine kinase, PROTEIN2 and MEK",IEPA.d60.s156
200,IEPA.d61,True,Secreted form of PROTEIN1 precursor protein activates protein kinase C and PROTEIN2 in cultured embryonic rat neocortical cells,IEPA.d61.s157
201,IEPA.d61,True,"Furthermore, we demonstrate that tyrosine phosphorylation of PROTEIN1 and formation of inositol 1,4,5-trisphosphate were increased by PROTEIN2 stimulation",IEPA.d61.s158
202,IEPA.d62,True," PROTEIN1 treated male rats had increased circulating levels of cholecystokinin, a tendency to increased plasma levels of PROTEIN2 (p = 0.066), and relatively more adipose tissue in the thigh and interscapular region, compared with controls",IEPA.d62.s159
203,IEPA.d63,True,"However, in brown fat, we observed a 2-3-fold increase in the expression of PROTEIN1 in response to dietary fat challenge, which may be related to diet-induced elevations in plasma PROTEIN2 levels",IEPA.d63.s160
204,IEPA.d65,True, PROTEIN1 induced activation of PROTEIN2 in renal epithelial cells,IEPA.d65.s163
205,IEPA.d65,True," PROTEIN1 induced a biphasic increase in diacylglycerol generation, characterized by an initial rapid rise and then a sustained elevation, and PROTEIN2 activation, reflected by phosphorylation of a specific 80 kDa myristoylated alanine-rich PKC substrate (MARCKS)",IEPA.d65.s164
206,IEPA.d65,True,"These results argue that Ca(2+)-dependent PROTEIN1 is involved in the action of PROTEIN2 and that of other agonists, which stimulate sodium transport",IEPA.d65.s165
207,IEPA.d66,True,"However, the PROTEIN1 dependent stimulation required activation of PROTEIN2 (PKC), whereas the inhibition was PROTEIN independent, indicating that the NGF-induced signaling pathways leading to inhibition and stimulation of HCO3- absorption are distinct",IEPA.d66.s166
208,IEPA.d66,False,"However, the PROTEIN1 dependent stimulation required activation of PROTEIN (PKC), whereas the inhibition was PROTEIN2 independent, indicating that the NGF-induced signaling pathways leading to inhibition and stimulation of HCO3- absorption are distinct",IEPA.d66.s166
209,IEPA.d66,False,"However, the PROTEIN dependent stimulation required activation of PROTEIN1 (PKC), whereas the inhibition was PROTEIN2 independent, indicating that the NGF-induced signaling pathways leading to inhibition and stimulation of HCO3- absorption are distinct",IEPA.d66.s166
210,IEPA.d67,False,Association of the insulin receptor with PROTEIN1 (PLCgamma) in 3T3-L1 adipocytes suggests a role for PROTEIN2 in metabolic signaling by PROTEIN ,IEPA.d67.s167
211,IEPA.d67,True,Association of the insulin receptor with PROTEIN (PLCgamma) in 3T3-L1 adipocytes suggests a role for PROTEIN1 in metabolic signaling by PROTEIN2 ,IEPA.d67.s167
212,IEPA.d67,False,Association of the insulin receptor with PROTEIN1 (PLCgamma) in 3T3-L1 adipocytes suggests a role for PROTEIN in metabolic signaling by PROTEIN2 ,IEPA.d67.s167
213,IEPA.d67,False,"To determine the functional significance of the interaction of PROTEIN and the IR, we used a specific inhibitor of PROTEIN U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PROTEIN1 to block PROTEIN2 stimulated GLUT4 translocation",IEPA.d67.s168
214,IEPA.d67,False,"To determine the functional significance of the interaction of PROTEIN1 and the IR, we used a specific inhibitor of PROTEIN U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PROTEIN2 to block PROTEIN stimulated GLUT4 translocation",IEPA.d67.s168
215,IEPA.d67,False,"To determine the functional significance of the interaction of PROTEIN and the IR, we used a specific inhibitor of PROTEIN1 U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PROTEIN2 to block PROTEIN stimulated GLUT4 translocation",IEPA.d67.s168
216,IEPA.d67,False,"To determine the functional significance of the interaction of PROTEIN1 and the IR, we used a specific inhibitor of PROTEIN U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PROTEIN to block PROTEIN2 stimulated GLUT4 translocation",IEPA.d67.s168
217,IEPA.d67,False,"To determine the functional significance of the interaction of PROTEIN and the IR, we used a specific inhibitor of PROTEIN1 U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PROTEIN to block PROTEIN2 stimulated GLUT4 translocation",IEPA.d67.s168
218,IEPA.d67,False,"To determine the functional significance of the interaction of PROTEIN1 and the IR, we used a specific inhibitor of PROTEIN2 U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PROTEIN to block PROTEIN stimulated GLUT4 translocation",IEPA.d67.s168
219,IEPA.d70,False,Inhibition of 5-HT3 serotonergic receptors with ondansetron (4 or 8 mg) did not modify the basal secretion of AVP and PROTEIN1 and the PROTEIN response to PROTEIN2 induced hypoglycemia,IEPA.d70.s171
220,IEPA.d70,True,Inhibition of 5-HT3 serotonergic receptors with ondansetron (4 or 8 mg) did not modify the basal secretion of AVP and PROTEIN and the PROTEIN1 response to PROTEIN2 induced hypoglycemia,IEPA.d70.s171
221,IEPA.d70,False,Inhibition of 5-HT3 serotonergic receptors with ondansetron (4 or 8 mg) did not modify the basal secretion of AVP and PROTEIN1 and the PROTEIN2 response to PROTEIN induced hypoglycemia,IEPA.d70.s171
222,IEPA.d71,True,HvSPY coexpression largely abolished PROTEIN1 induced activity of an PROTEIN2 promoter.,IEPA.d71.s172
223,IEPA.d72,True,"Treatment with (+)-trifluoro-ABA strongly inhibited the PROTEIN1 inducible expression of PROTEIN2 I-1 encoded by RAmy1A in the aleurone layers of embryoless half-seeds at the levels of transcription, protein synthesis, and enzyme activity",IEPA.d72.s173
224,IEPA.d73,False,"Furthermore, treatment of isolated rat diaphragms and adipocytes with PIG-P as well as with other agents exerting partially PROTEIN1 mimetic activity, such as PI-specific PROTEIN2 (PLC) and the sulfonylurea glimepiride, triggered tyrosine phosphorylation of the caveolar marker protein caveolin, which was apparently correlated with stimulation of lipogenesis",IEPA.d73.s174
225,IEPA.d73,False,"Strikingly, in adipocytes subjected to combined trypsin/salt treatment, PIG-P, PI-specific PROTEIN1 and glimepiride failed completely to provoke PROTEIN2 mimetic effects",IEPA.d73.s175
226,IEPA.d74,True,Chronic central PROTEIN1 infusion enhances insulin-stimulated glucose metabolism and favors the expression of PROTEIN2 ,IEPA.d74.s176
227,IEPA.d74,True,"In marked contrast, intracerebroventricular PROTEIN1 administration was accompanied by the maintenance of high PROTEIN PROTEIN2 and PROTEIN expression in all these tissues",IEPA.d74.s177
228,IEPA.d74,False,"In marked contrast, intracerebroventricular PROTEIN administration was accompanied by the maintenance of high PROTEIN PROTEIN1 and PROTEIN2 expression in all these tissues",IEPA.d74.s177
229,IEPA.d74,False,"In marked contrast, intracerebroventricular PROTEIN administration was accompanied by the maintenance of high PROTEIN1 PROTEIN2 and PROTEIN expression in all these tissues",IEPA.d74.s177
230,IEPA.d74,True,"In marked contrast, intracerebroventricular PROTEIN1 administration was accompanied by the maintenance of high PROTEIN PROTEIN and PROTEIN2 expression in all these tissues",IEPA.d74.s177
231,IEPA.d74,True,"In marked contrast, intracerebroventricular PROTEIN1 administration was accompanied by the maintenance of high PROTEIN2 PROTEIN and PROTEIN expression in all these tissues",IEPA.d74.s177
232,IEPA.d74,False,"In marked contrast, intracerebroventricular PROTEIN administration was accompanied by the maintenance of high PROTEIN1 PROTEIN and PROTEIN2 expression in all these tissues",IEPA.d74.s177
233,IEPA.d74,True,"While PROTEIN1 maintains or favors energy-dissipating mechanisms ( PROTEIN2 PROTEIN and PROTEIN , the latter are markedly depressed in pair-fed rats",IEPA.d74.s178
234,IEPA.d74,False,"While PROTEIN maintains or favors energy-dissipating mechanisms ( PROTEIN1 PROTEIN and PROTEIN2 , the latter are markedly depressed in pair-fed rats",IEPA.d74.s178
235,IEPA.d74,False,"While PROTEIN maintains or favors energy-dissipating mechanisms ( PROTEIN1 PROTEIN2 and PROTEIN , the latter are markedly depressed in pair-fed rats",IEPA.d74.s178
236,IEPA.d74,True,"While PROTEIN1 maintains or favors energy-dissipating mechanisms ( PROTEIN PROTEIN and PROTEIN2 , the latter are markedly depressed in pair-fed rats",IEPA.d74.s178
237,IEPA.d74,True,"While PROTEIN1 maintains or favors energy-dissipating mechanisms ( PROTEIN PROTEIN2 and PROTEIN , the latter are markedly depressed in pair-fed rats",IEPA.d74.s178
238,IEPA.d74,False,"While PROTEIN maintains or favors energy-dissipating mechanisms ( PROTEIN PROTEIN1 and PROTEIN2 , the latter are markedly depressed in pair-fed rats",IEPA.d74.s178
239,IEPA.d76,True,"Melatonin inhibits PROTEIN1 response to PROTEIN2 induced hypoglycemia, but not to angiotensin II in normal men",IEPA.d76.s182
240,IEPA.d76,False,"In order to establish whether melatonin alters basal and/or stimulated PROTEIN1 secretion, 18 normal men were treated (p.o.) with 6 or 12 mg melatonin or placebo in basal conditions (N-6 subjects) or concomitantly to the administration of PROTEIN2 (O.15 IU/kg body weight in an i.v. bolus) (N-6 subjects) or angiotensin II (increasing doses of 4, 8 and 16 ng/kg/min, at intervals of 20 min)",IEPA.d76.s183
241,IEPA.d76,True,"In contrast, the PROTEIN1 response to PROTEIN2 induced hypoglycemia was significantly reduced by melatonin treatment",IEPA.d76.s184
242,IEPA.d77,False,"Although osmotic stimuli cause an increase in nitric oxide synthase (NOS) activity as well as synthesis of AVP and PROTEIN1 in the paraventricular (PVN) and supraoptic nuclei (SON), it is not known whether NOS activity in the hypothalamus changes in the diabetic patients who have plasma hyperosmolality with hyperglycaemia caused by PROTEIN2 deficiency",IEPA.d77.s185
243,IEPA.d77,True,"Three weeks after administration of STZ, the diabetic rats were subcutaneously treated with PROTEIN1 for 1 week, which resulted in significant suppression of the induction of nNOS, AVP and PROTEIN2 gene expression in the PVN and SON",IEPA.d77.s186
244,IEPA.d79,False, PROTEIN1 evokes the release of Ca2+ from PROTEIN2 sensitive intracellular stores,IEPA.d79.s189
245,IEPA.d80,False,"To explore the possible roles of the hypothalamic melanocortin system in PROTEIN1 action, we examined the effects of intracerebroventricular (i.c.v.) injection of PROTEIN with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial PROTEIN2 (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats",IEPA.d80.s190
246,IEPA.d80,False,"To explore the possible roles of the hypothalamic melanocortin system in PROTEIN1 action, we examined the effects of intracerebroventricular (i.c.v.) injection of PROTEIN2 with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial PROTEIN (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats",IEPA.d80.s190
247,IEPA.d80,False,"To explore the possible roles of the hypothalamic melanocortin system in PROTEIN action, we examined the effects of intracerebroventricular (i.c.v.) injection of PROTEIN1 with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial PROTEIN2 (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats",IEPA.d80.s190
248,IEPA.d80,True,"A single i.c.v. injection of PROTEIN1 decreased cumulative food intake and body weight gain, and increased PROTEIN2 mRNA expression during 3 h at the onset of the dark phase",IEPA.d80.s191
249,IEPA.d80,True,Co-injection of SHU9119 also inhibited completely the PROTEIN1 induced increase in PROTEIN2 mRNA expression in the BAT,IEPA.d80.s192
250,IEPA.d81,True,"It has been established that PROTEIN1 beta peptide (AbetaP) activates phospholipase A2, PROTEIN2 and phospholipase D of LA-N-2 cells and other cell types",IEPA.d81.s193
251,IEPA.d81,True,(-)Nicotine did not blunt the PROTEIN1 activation of PROTEIN2 ,IEPA.d81.s194
252,IEPA.d82,True,Neural site of PROTEIN1 influence on neuropeptide Y signaling pathways altering feeding and PROTEIN2 ,IEPA.d82.s195
253,IEPA.d82,False,"NPY in the PVN increases feeding and decreases PROTEIN1 (UCP) activity in brown fat, whereas PROTEIN2 decreases NPY biosynthesis in the Arc, which presumably decreases PVN NPY",IEPA.d82.s196
254,IEPA.d82,True,"Next, we determined that PROTEIN1 decreases NPY and increases PROTEIN2 gene expression",IEPA.d82.s197
255,IEPA.d83,False,"Furthermore, immunocytochemical studies showed the PROTEIN1 induced neuronal MAC expression on the SH-SY5Y cells after CD59 was removed by PROTEIN2 or blocked by anti-CD59 antibody",IEPA.d83.s198
256,IEPA.d84,False,Effect of residual endogenous PROTEIN1 secretion on the abnormal PROTEIN response to hypoglycaemia in PROTEIN2 dependent diabetics,IEPA.d84.s199
257,IEPA.d84,True,Effect of residual endogenous PROTEIN1 secretion on the abnormal PROTEIN2 response to hypoglycaemia in PROTEIN dependent diabetics,IEPA.d84.s199
258,IEPA.d84,False,Effect of residual endogenous PROTEIN secretion on the abnormal PROTEIN1 response to hypoglycaemia in PROTEIN2 dependent diabetics,IEPA.d84.s199
259,IEPA.d84,True,"Since previous studies showed that AVP secretion is influenced by the persistence of residual endogenous PROTEIN1 secretion, we wondered whether this factor also regulates PROTEIN2 secretion",IEPA.d84.s200
260,IEPA.d84,False,DESIGN: Case-control study: the PROTEIN response to PROTEIN1 induced hypoglycaemia was measured in normal and diabetic patients with or without residual endogenous PROTEIN2 secretion,IEPA.d84.s201
261,IEPA.d84,False,DESIGN: Case-control study: the PROTEIN1 response to PROTEIN induced hypoglycaemia was measured in normal and diabetic patients with or without residual endogenous PROTEIN2 secretion,IEPA.d84.s201
262,IEPA.d84,True,DESIGN: Case-control study: the PROTEIN1 response to PROTEIN2 induced hypoglycaemia was measured in normal and diabetic patients with or without residual endogenous PROTEIN secretion,IEPA.d84.s201
263,IEPA.d84,False,"Blood samples for PROTEIN1 assay were taken just before the rapid injection of PROTEIN2 (time 0) and at time 15, 30, 45 and 60 min",IEPA.d84.s202
264,IEPA.d84,True,CONCLUSIONS: These data indicate that a residual endogenous PROTEIN1 secretion exerts a partial protective action against the hypothalamic-pituitary disorder affecting the PROTEIN2 secretory system in IDDM,IEPA.d84.s203
265,IEPA.d85,True,A barley gene encoding a novel DNA-binding protein (HRT) was identified by southwestern screening with baits containing a PROTEIN1 phytohormone response element from an PROTEIN2 promoter,IEPA.d85.s204
266,IEPA.d86,True,"These observations suggest that bradykinin, like PROTEIN1 activates phospholipase C which generates PROTEIN2 with a subsequent release of Ca2+ from intracellular stores followed by store-operated Ca2+ influx",IEPA.d86.s205
267,IEPA.d87,True,These findings led us to conclude that inositol trisphosphate [corrected] causes Ca2+ mobilization by muscarinic activation of PROTEIN1 leading to intracellular translocation of PROTEIN2 granules to the ready-releasable pool in pancreatic beta-cells via Ca2+/calmodulin-dependent phosphorylation of myosin light chains,IEPA.d87.s206
268,IEPA.d88,False,"To elucidate the pathophysiologic significance of PROTEIN and PROTEIN in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with PROTEIN receptor defect, and investigated expression of the genes encoding PROTEIN1 and PROTEIN2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207
269,IEPA.d88,False,"To elucidate the pathophysiologic significance of PROTEIN1 and PROTEIN in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with PROTEIN receptor defect, and investigated expression of the genes encoding PROTEIN2 and PROTEIN in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207
270,IEPA.d88,False,"To elucidate the pathophysiologic significance of PROTEIN and PROTEIN in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with PROTEIN1 receptor defect, and investigated expression of the genes encoding PROTEIN2 and PROTEIN in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207
271,IEPA.d88,False,"To elucidate the pathophysiologic significance of PROTEIN and PROTEIN1 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with PROTEIN receptor defect, and investigated expression of the genes encoding PROTEIN2 and PROTEIN in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207
272,IEPA.d88,False,"To elucidate the pathophysiologic significance of PROTEIN1 and PROTEIN in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with PROTEIN receptor defect, and investigated expression of the genes encoding PROTEIN and PROTEIN2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207
273,IEPA.d88,False,"To elucidate the pathophysiologic significance of PROTEIN and PROTEIN in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with PROTEIN1 receptor defect, and investigated expression of the genes encoding PROTEIN and PROTEIN2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207
274,IEPA.d88,False,"To elucidate the pathophysiologic significance of PROTEIN and PROTEIN1 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with PROTEIN receptor defect, and investigated expression of the genes encoding PROTEIN and PROTEIN2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207
275,IEPA.d88,False,"To elucidate the pathophysiologic significance of PROTEIN1 and PROTEIN in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with PROTEIN2 receptor defect, and investigated expression of the genes encoding PROTEIN and PROTEIN in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207
276,IEPA.d88,False,"To elucidate the pathophysiologic significance of PROTEIN1 and PROTEIN2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with PROTEIN receptor defect, and investigated expression of the genes encoding PROTEIN and PROTEIN in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207
277,IEPA.d88,False,"To elucidate the pathophysiologic significance of PROTEIN and PROTEIN1 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with PROTEIN2 receptor defect, and investigated expression of the genes encoding PROTEIN and PROTEIN in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207
278,IEPA.d88,False,"These results clearly demonstrate that PROTEIN gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with PROTEIN1 receptor defect, and that adipose PROTEIN2 gene expression is increased in response to TZDs in vitro",IEPA.d88.s208
279,IEPA.d88,False,"These results clearly demonstrate that PROTEIN1 gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with PROTEIN2 receptor defect, and that adipose PROTEIN gene expression is increased in response to TZDs in vitro",IEPA.d88.s208
280,IEPA.d88,False,"These results clearly demonstrate that PROTEIN1 gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with PROTEIN receptor defect, and that adipose PROTEIN2 gene expression is increased in response to TZDs in vitro",IEPA.d88.s208
281,IEPA.d89,False, PROTEIN1 PROTEIN2 and PROTEIN gene expression: modulation by food restriction and PROTEIN ,IEPA.d89.s209
282,IEPA.d89,True, PROTEIN1 PROTEIN and PROTEIN gene expression: modulation by food restriction and PROTEIN2 ,IEPA.d89.s209
283,IEPA.d89,False, PROTEIN1 PROTEIN and PROTEIN2 gene expression: modulation by food restriction and PROTEIN ,IEPA.d89.s209
284,IEPA.d89,True, PROTEIN PROTEIN1 and PROTEIN gene expression: modulation by food restriction and PROTEIN2 ,IEPA.d89.s209
285,IEPA.d89,False, PROTEIN PROTEIN1 and PROTEIN2 gene expression: modulation by food restriction and PROTEIN ,IEPA.d89.s209
286,IEPA.d89,False, PROTEIN PROTEIN and PROTEIN1 gene expression: modulation by food restriction and PROTEIN2 ,IEPA.d89.s209
287,IEPA.d89,False,"To determine the effects of food restriction and PROTEIN1 administration on several transcripts involved in energy homeostasis, we examined PROTEIN2 PROTEIN (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats",IEPA.d89.s210
288,IEPA.d89,False,"To determine the effects of food restriction and PROTEIN1 administration on several transcripts involved in energy homeostasis, we examined PROTEIN PROTEIN2 (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats",IEPA.d89.s210
289,IEPA.d89,False,"To determine the effects of food restriction and PROTEIN administration on several transcripts involved in energy homeostasis, we examined PROTEIN1 PROTEIN2 (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats",IEPA.d89.s210
290,IEPA.d89,True," PROTEIN1 increased LPL mRNA by 80%, PROTEIN mRNA twofold, and PROTEIN mRNA levels by 62% in BAT, and increased PROTEIN2 mRNA levels twofold in EWAT",IEPA.d89.s211
291,IEPA.d89,False," PROTEIN increased LPL mRNA by 80%, PROTEIN1 mRNA twofold, and PROTEIN mRNA levels by 62% in BAT, and increased PROTEIN2 mRNA levels twofold in EWAT",IEPA.d89.s211
292,IEPA.d89,False," PROTEIN increased LPL mRNA by 80%, PROTEIN mRNA twofold, and PROTEIN1 mRNA levels by 62% in BAT, and increased PROTEIN2 mRNA levels twofold in EWAT",IEPA.d89.s211
293,IEPA.d89,True," PROTEIN1 increased LPL mRNA by 80%, PROTEIN2 mRNA twofold, and PROTEIN mRNA levels by 62% in BAT, and increased PROTEIN mRNA levels twofold in EWAT",IEPA.d89.s211
294,IEPA.d89,True," PROTEIN1 increased LPL mRNA by 80%, PROTEIN mRNA twofold, and PROTEIN2 mRNA levels by 62% in BAT, and increased PROTEIN mRNA levels twofold in EWAT",IEPA.d89.s211
295,IEPA.d89,False," PROTEIN increased LPL mRNA by 80%, PROTEIN1 mRNA twofold, and PROTEIN2 mRNA levels by 62% in BAT, and increased PROTEIN mRNA levels twofold in EWAT",IEPA.d89.s211
296,IEPA.d89,False,"The present study indicates that PROTEIN increases the gene expression of PROTEIN in EWAT and that of PROTEIN1 PROTEIN2 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT",IEPA.d89.s212
297,IEPA.d89,True,"The present study indicates that PROTEIN1 increases the gene expression of PROTEIN in EWAT and that of PROTEIN PROTEIN2 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT",IEPA.d89.s212
298,IEPA.d89,False,"The present study indicates that PROTEIN increases the gene expression of PROTEIN1 in EWAT and that of PROTEIN PROTEIN2 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT",IEPA.d89.s212
299,IEPA.d89,True,"The present study indicates that PROTEIN1 increases the gene expression of PROTEIN in EWAT and that of PROTEIN2 PROTEIN and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT",IEPA.d89.s212
300,IEPA.d89,False,"The present study indicates that PROTEIN increases the gene expression of PROTEIN1 in EWAT and that of PROTEIN2 PROTEIN and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT",IEPA.d89.s212
301,IEPA.d89,True,"The present study indicates that PROTEIN1 increases the gene expression of PROTEIN2 in EWAT and that of PROTEIN PROTEIN and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT",IEPA.d89.s212
302,IEPA.d90,True,DNase1 footprints suggest the involvement of at least three types of transcription factors in the regulation of PROTEIN1 by PROTEIN2 ,IEPA.d90.s213
303,IEPA.d90,True,The regulation of PROTEIN1 genes by PROTEIN2 therefore involves an interplay of at least three different types of transcription factor,IEPA.d90.s214
304,IEPA.d91,True,Oxytocin-stimulated PROTEIN1 release in a clonal beta-cell line RINm5F: involvement of PROTEIN2 dependent and -independent pathways.,IEPA.d91.s215
305,IEPA.d91,True,CONCLUSION: Oxy increases PROTEIN1 release through both PROTEIN2 and non-PLC mediated signal transduction mechanisms.,IEPA.d91.s216
306,IEPA.d91,True,"In addition, U-73122 diminished the PROTEIN1 induced increase in intracellular concentration of PROTEIN2 (IP3)",IEPA.d91.s217
307,IEPA.d91,False,"U-73122 at 8 mumol.L-1 totally abolished the PROTEIN induced increases in [Ca2+]i and PROTEIN1 however it reduced the PROTEIN2 induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively",IEPA.d91.s218
308,IEPA.d91,False,"U-73122 at 8 mumol.L-1 totally abolished the PROTEIN1 induced increases in [Ca2+]i and PROTEIN however it reduced the PROTEIN2 induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively",IEPA.d91.s218
309,IEPA.d91,True,"U-73122 at 8 mumol.L-1 totally abolished the PROTEIN1 induced increases in [Ca2+]i and PROTEIN2 however it reduced the PROTEIN induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively",IEPA.d91.s218
310,IEPA.d91,True, PROTEIN1 stimulated PROTEIN2 release in a clonal beta-cell line RINm5F: involvement of phospholipase C-dependent and -independent pathways,IEPA.d91.s219
311,IEPA.d91,True,AIM: To study the mechanisms underlying PROTEIN1 (Oxy)-induced PROTEIN2 release,IEPA.d91.s220
312,IEPA.d91,True,RESULTS: PROTEIN1 increased PROTEIN2 release and [Ca2+]i in a concentration-dependent manner,IEPA.d91.s221
313,IEPA.d91,True, PROTEIN1 induced PROTEIN2 release was not altered by pretreatment with pertussis toxin (PT),IEPA.d91.s222
314,IEPA.d91,True,"U-73122 at 8 mumol.L-1 totally abolished the PROTEIN induced increases in [Ca2+]i and IP3; however it reduced the PROTEIN1 induced increase in PROTEIN2 release only by 36% and 63% in the monolayer and suspended cell preparations, respectively",IEPA.d91.s223
315,IEPA.d91,False,"U-73122 at 8 mumol.L-1 totally abolished the PROTEIN1 induced increases in [Ca2+]i and IP3; however it reduced the PROTEIN induced increase in PROTEIN2 release only by 36% and 63% in the monolayer and suspended cell preparations, respectively",IEPA.d91.s223
316,IEPA.d91,False,"U-73122 at 8 mumol.L-1 totally abolished the PROTEIN1 induced increases in [Ca2+]i and IP3; however it reduced the PROTEIN2 induced increase in PROTEIN release only by 36% and 63% in the monolayer and suspended cell preparations, respectively",IEPA.d91.s223
317,IEPA.d91,True,CONCLUSION: PROTEIN1 increases PROTEIN2 release through both PLC and non-PLC mediated signal transduction mechanisms,IEPA.d91.s224
318,IEPA.d92,False,"In isolated adipocytes, the loss of almost half the 18S RNA content over a 24-hour incubation was prevented in the presence of PROTEIN1 but not PROTEIN2 or epidermal growth factor (EGF)",IEPA.d92.s225
319,IEPA.d93,True,"Further investigation suggested that activation of PROTEIN1 (PKC), which is part of the PROTEIN2 induced intracellular signalling pathway, is necessary and sufficient for the generation of the synergistic response, although it is not obligatory for PROTEIN induced ACTH release",IEPA.d93.s226
320,IEPA.d93,False,"Further investigation suggested that activation of PROTEIN (PKC), which is part of the PROTEIN1 induced intracellular signalling pathway, is necessary and sufficient for the generation of the synergistic response, although it is not obligatory for PROTEIN2 induced ACTH release",IEPA.d93.s226
321,IEPA.d93,False,"Further investigation suggested that activation of PROTEIN1 (PKC), which is part of the PROTEIN induced intracellular signalling pathway, is necessary and sufficient for the generation of the synergistic response, although it is not obligatory for PROTEIN2 induced ACTH release",IEPA.d93.s226
322,IEPA.d94,False," PROTEIN1 (OT) is more expressed in the TEC/TNC than vasopressin (VP); insulin-like growth factor 2 (IGF-2) thymic expression predominates over IGF-1, and much more over PROTEIN2 ",IEPA.d94.s227
323,IEPA.d94,False,"Thus, PROTEIN1 was proposed to be the self antigen of the neurohypophysial family, and IGF-2 the self antigen precursor of the PROTEIN2 family",IEPA.d94.s228
324,IEPA.d96,True,Downregulation of PROTEIN1 mRNA in white adipose tissue and PROTEIN mRNA in skeletal muscle during the early stages of PROTEIN2 treatment,IEPA.d96.s231
325,IEPA.d96,False,Downregulation of PROTEIN1 mRNA in white adipose tissue and PROTEIN2 mRNA in skeletal muscle during the early stages of PROTEIN treatment,IEPA.d96.s231
326,IEPA.d96,True,Downregulation of PROTEIN mRNA in white adipose tissue and PROTEIN1 mRNA in skeletal muscle during the early stages of PROTEIN2 treatment,IEPA.d96.s231
327,IEPA.d96,True, PROTEIN1 by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in PROTEIN2 mRNA in WAT (47-52%) and PROTEIN mRNA in SM (33-37%),IEPA.d96.s232
328,IEPA.d96,False, PROTEIN by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in PROTEIN1 mRNA in WAT (47-52%) and PROTEIN2 mRNA in SM (33-37%),IEPA.d96.s232
329,IEPA.d96,True, PROTEIN1 by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in PROTEIN mRNA in WAT (47-52%) and PROTEIN2 mRNA in SM (33-37%),IEPA.d96.s232
330,IEPA.d96,False,"Denervation suppressed mRNA levels for PROTEIN1 (49%), PROTEIN (36%), and COX-IV (59%) and eliminated the acute response to PROTEIN2 in SM",IEPA.d96.s233
331,IEPA.d96,False,"Denervation suppressed mRNA levels for PROTEIN1 (49%), PROTEIN2 (36%), and COX-IV (59%) and eliminated the acute response to PROTEIN in SM",IEPA.d96.s233
332,IEPA.d96,False,"Denervation suppressed mRNA levels for PROTEIN (49%), PROTEIN1 (36%), and COX-IV (59%) and eliminated the acute response to PROTEIN2 in SM",IEPA.d96.s233
333,IEPA.d97,True,"The specific PROTEIN1 (PKC) inhibitor chelerythrine (5 micrometers) inhibited PTH-, PROTEIN2 , PGE2-, and adenosine-stimulated Ca2+ reabsorption by 77%, 67%, 79%, and 100%, respectively",IEPA.d97.s234
334,IEPA.d97,True,"CONCLUSION: PTH, PROTEIN1 PGE2, and adenosine stimulate Ca2+ reabsorption via a pathway that is independent of cAMP and that involves a phorbol ester-insensitive PROTEIN2 isotype",IEPA.d97.s235
335,IEPA.d98,True,We observed that primary microglial cultures and the THP-1 monocytic cell line are stimulated by fibrillar beta-amyloid and PROTEIN1 peptides to activate identical PROTEIN2 dependent inflammatory signal transduction cascades,IEPA.d98.s236
336,IEPA.d99,True,Enhanced phosphoinositide hydrolysis via overexpression of PROTEIN1 beta1 or delta1 inhibits stimulus-induced PROTEIN2 release in insulinoma MIN6 cells.,IEPA.d99.s237
337,IEPA.d99,False,"To study the effects of enhanced phosphoinositide hydrolysis on PROTEIN1 secretion, phosphoinositide-specific PROTEIN (PLCbeta1) or PROTEIN2 was overexpressed in insulinoma MIN6 cells via adenoviral vectors.",IEPA.d99.s238
338,IEPA.d99,False,"To study the effects of enhanced phosphoinositide hydrolysis on PROTEIN secretion, phosphoinositide-specific PROTEIN1 (PLCbeta1) or PROTEIN2 was overexpressed in insulinoma MIN6 cells via adenoviral vectors.",IEPA.d99.s238
339,IEPA.d99,False,"To study the effects of enhanced phosphoinositide hydrolysis on PROTEIN1 secretion, phosphoinositide-specific PROTEIN2 (PLCbeta1) or PROTEIN was overexpressed in insulinoma MIN6 cells via adenoviral vectors.",IEPA.d99.s238
340,IEPA.d100,True,"If daily PROTEIN1 injections are repeated over a 5-day period, blood pressure is decreased by 10-20 mmHg, the withdrawal latency to heat stimuli is prolonged, cortisol levels are decreased and PROTEIN2 and cholecystokinin levels are increased",IEPA.d100.s239
341,IEPA.d104,False,"In addition, abscisic acid-mediated inhibition of PROTEIN1 stimulated responses seems to depend on the activation of a phospholipase D during induction of PROTEIN2 in barley aleurone cells as well as on a putative acetyltransferase involved in elongation growth.",IEPA.d104.s243
342,IEPA.d106,False," PROTEIN1 (PKC) inhibitors reversed PROTEIN inhibition, whereas PROTEIN2 activator inhibited nitrite production",IEPA.d106.s245
343,IEPA.d106,True," PROTEIN1 (PKC) inhibitors reversed PROTEIN2 inhibition, whereas PROTEIN activator inhibited nitrite production",IEPA.d106.s245
344,IEPA.d106,False," PROTEIN (PKC) inhibitors reversed PROTEIN1 inhibition, whereas PROTEIN2 activator inhibited nitrite production",IEPA.d106.s245
345,IEPA.d106,True,The inhibitory action of PROTEIN1 involves both the activation of PROTEIN2 and the transcription of iNOS mRNA in cultured rat GMC,IEPA.d106.s246
346,IEPA.d107,True,Molecular characterization of catalytic-subunit cDNA sequences encoding protein phosphatases 1 and 2A and study of their roles in the PROTEIN1 dependent PROTEIN2 expression in rice,IEPA.d107.s247
347,IEPA.d107,True,"To understand the molecular mechanism of PROTEIN1 dependent gene regulation, the effect of three phosphatase inhibitors on the germination of rice seeds and the expression of a target gene, the PROTEIN2 gene, Osamy-c, were measured",IEPA.d107.s248
348,IEPA.d107,True,To further understand the possible role of protein phosphatases 1 and 2A in the PROTEIN1 dependent expression of PROTEIN2 we isolated cDNA clones encoding protein phosphatase 1 and protein phosphatase 2A from a rice aleurone cDNA library,IEPA.d107.s249
349,IEPA.d107,True,"Taken together, our results suggest that protein phosphatases PP1 or PP2A are involved in the PROTEIN1 dependent expression of the rice PROTEIN2 gene, though the PP1 or/and PP2A enzymatic activities as well as mRNA levels do not increase upon GA3 treatment",IEPA.d107.s250
350,IEPA.d109,True,Fasting and PROTEIN1 modulate adipose and muscle PROTEIN2 divergent effects between messenger ribonucleic acid and protein expression,IEPA.d109.s256
351,IEPA.d109,False,"In this study, we examined the effects of fasting for 2 days and exogenous s.c. PROTEIN1 200 microg every 8 h for 2 days, on the regulation of PROTEIN2 (UCP) subtypes in brown adipose tissue (BAT) and gastrocnemius muscle",IEPA.d109.s257
352,IEPA.d109,False," PROTEIN1 compared with vehicle, did not alter BAT PROTEIN2 or PROTEIN mRNA or protein expression when administered to normal ad libitum fed rats",IEPA.d109.s258
353,IEPA.d109,False," PROTEIN compared with vehicle, did not alter BAT PROTEIN1 or PROTEIN2 mRNA or protein expression when administered to normal ad libitum fed rats",IEPA.d109.s258
354,IEPA.d109,False," PROTEIN1 compared with vehicle, did not alter BAT PROTEIN or PROTEIN2 mRNA or protein expression when administered to normal ad libitum fed rats",IEPA.d109.s258
355,IEPA.d109,False,"Fasting significantly decreased BAT PROTEIN1 and PROTEIN2 mRNA expression, to 31% and 30% of ad libitum fed controls, respectively, effects which were prevented by administration of PROTEIN to fasted rats",IEPA.d109.s259
356,IEPA.d109,True,"Fasting significantly decreased BAT PROTEIN1 and PROTEIN mRNA expression, to 31% and 30% of ad libitum fed controls, respectively, effects which were prevented by administration of PROTEIN2 to fasted rats",IEPA.d109.s259
357,IEPA.d109,True,"Fasting significantly decreased BAT PROTEIN and PROTEIN1 mRNA expression, to 31% and 30% of ad libitum fed controls, respectively, effects which were prevented by administration of PROTEIN2 to fasted rats",IEPA.d109.s259
358,IEPA.d109,False,"Fasting also significantly decreased BAT PROTEIN1 protein expression, to 67% of control; however, that effect was not prevented by PROTEIN2 treatment",IEPA.d109.s260
359,IEPA.d109,False,"Fasting, with or without PROTEIN1 administration, did not affect BAT PROTEIN mRNA; however, PROTEIN2 administration to ad libitum fed rats significantly increased BAT PROTEIN mRNA, to 138% of control",IEPA.d109.s261
360,IEPA.d109,False,"Fasting, with or without PROTEIN1 administration, did not affect BAT PROTEIN2 mRNA; however, PROTEIN administration to ad libitum fed rats significantly increased BAT PROTEIN mRNA, to 138% of control",IEPA.d109.s261
361,IEPA.d109,False,"Fasting, with or without PROTEIN1 administration, did not affect BAT PROTEIN mRNA; however, PROTEIN administration to ad libitum fed rats significantly increased BAT PROTEIN2 mRNA, to 138% of control",IEPA.d109.s261
362,IEPA.d109,False,"Fasting, with or without PROTEIN administration, did not affect BAT PROTEIN1 mRNA; however, PROTEIN2 administration to ad libitum fed rats significantly increased BAT PROTEIN mRNA, to 138% of control",IEPA.d109.s261
363,IEPA.d109,True,"Fasting, with or without PROTEIN administration, did not affect BAT PROTEIN mRNA; however, PROTEIN1 administration to ad libitum fed rats significantly increased BAT PROTEIN2 mRNA, to 138% of control",IEPA.d109.s261
364,IEPA.d109,False,"Fasting, with or without PROTEIN administration, did not affect BAT PROTEIN1 mRNA; however, PROTEIN administration to ad libitum fed rats significantly increased BAT PROTEIN2 mRNA, to 138% of control",IEPA.d109.s261
365,IEPA.d109,False,"Fasting significantly enhanced gastrocnemius muscle PROTEIN1 mRNA (411% of control) and protein expression (168% of control), whereas PROTEIN2 administration to fasted rats did not alter either of these effects",IEPA.d109.s262
366,IEPA.d109,True,"In summary, PROTEIN1 subtype mRNA and protein are regulated in tissue- and subtype-specific fashion by PROTEIN2 and food restriction",IEPA.d109.s263
367,IEPA.d111,False,"Plasma PROTEIN1 and some functionally related peptides (CCK, gastrin, somatostatin and PROTEIN2 , were measured by standard radioimmunoassay techniques",IEPA.d111.s269
368,IEPA.d112,True,"Analyses of hormone regulation of expression of mRNA for the aleurone RNase revealed that, like the pattern for PROTEIN1 mRNA levels increased in the presence of PROTEIN2 and its antagonist abscisic acid prevented this effect",IEPA.d112.s270
369,IEPA.d112,True,"Quantitative studies at early times demonstrated that cycloheximide treatment of aleurone layers increased mRNA levels 4-fold, whereas a combination of PROTEIN1 plus cycloheximide treatment was required to increase PROTEIN2 mRNA levels to the same extent",IEPA.d112.s271
370,IEPA.d113,False,"The experiments were concluded by taking blood samples for later analysis of plasma glucose and plasma levels of the following hormones: PROTEIN1 gastrin, CCK, glucagon, somatostatin, PROTEIN2 and corticosterone",IEPA.d113.s272
371,IEPA.d113,False,"The low-performing Stock B animals were characterized by [1] being more reactive to sensory stimulation: higher startle amplitude and shorter startle latency; [2] having higher plasma PROTEIN1 and corticosterone levels, whereas plasma gastrin and PROTEIN2 were significantly lowered and a strong tendency for a decrease also in plasma CCK",IEPA.d113.s273
372,IEPA.d114,False,"In normal pancreatic islets, PROTEIN1 is upregulated by PROTEIN and is low in PROTEIN2 resistant islets of ZDF rats",IEPA.d114.s274
373,IEPA.d114,True,"In normal pancreatic islets, PROTEIN1 is upregulated by PROTEIN2 and is low in PROTEIN resistant islets of ZDF rats",IEPA.d114.s274
374,IEPA.d114,False,"In normal pancreatic islets, PROTEIN is upregulated by PROTEIN1 and is low in PROTEIN2 resistant islets of ZDF rats",IEPA.d114.s274
375,IEPA.d114,False,"To determine whether PROTEIN does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in PROTEIN unresponsive PROTEIN1 underexpressing islets of diabetic ZDF rats, we transferred the PROTEIN2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats",IEPA.d114.s275
376,IEPA.d114,False,"To determine whether PROTEIN does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in PROTEIN1 unresponsive PROTEIN2 underexpressing islets of diabetic ZDF rats, we transferred the PROTEIN gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats",IEPA.d114.s275
377,IEPA.d114,False,"To determine whether PROTEIN1 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in PROTEIN unresponsive PROTEIN2 underexpressing islets of diabetic ZDF rats, we transferred the PROTEIN gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats",IEPA.d114.s275
378,IEPA.d114,False,"To determine whether PROTEIN does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in PROTEIN1 unresponsive PROTEIN underexpressing islets of diabetic ZDF rats, we transferred the PROTEIN2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats",IEPA.d114.s275
379,IEPA.d114,False,"To determine whether PROTEIN1 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in PROTEIN unresponsive PROTEIN underexpressing islets of diabetic ZDF rats, we transferred the PROTEIN2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats",IEPA.d114.s275
380,IEPA.d114,False,"To determine whether PROTEIN1 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in PROTEIN2 unresponsive PROTEIN underexpressing islets of diabetic ZDF rats, we transferred the PROTEIN gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats",IEPA.d114.s275
381,IEPA.d114,False,"We conclude that PROTEIN1 has uncoupling function when overexpressed in PROTEIN2 insensitive islets and that its overexpression corrects the underexpression of the insulin gene and ameliorates glucose-stimulated insulin secretion, possibly by increasing the ATP:ADP ratio",IEPA.d114.s276
382,IEPA.d117,False,"The second class of mutant, gse ( PROTEIN sensitivity), differed principally in PROTEIN1 sensitivity, requiring approximately 100-fold higher [ PROTEIN for both leaf elongation and PROTEIN2 production by aleurone",IEPA.d117.s285
383,IEPA.d117,True,"The second class of mutant, gse ( PROTEIN sensitivity), differed principally in PROTEIN sensitivity, requiring approximately 100-fold higher [ PROTEIN1 for both leaf elongation and PROTEIN2 production by aleurone",IEPA.d117.s285
384,IEPA.d117,False,"The second class of mutant, gse ( PROTEIN1 sensitivity), differed principally in PROTEIN sensitivity, requiring approximately 100-fold higher [ PROTEIN for both leaf elongation and PROTEIN2 production by aleurone",IEPA.d117.s285
385,IEPA.d117,False,"The second class of mutant, gse ( PROTEIN sensitivity), differed principally in PROTEIN1 sensitivity, requiring approximately 100-fold higher [ PROTEIN2 for both leaf elongation and PROTEIN production by aleurone",IEPA.d117.s285
386,IEPA.d117,False,"The second class of mutant, gse ( PROTEIN1 sensitivity), differed principally in PROTEIN2 sensitivity, requiring approximately 100-fold higher [ PROTEIN for both leaf elongation and PROTEIN production by aleurone",IEPA.d117.s285
387,IEPA.d117,False,"The second class of mutant, gse ( PROTEIN1 sensitivity), differed principally in PROTEIN sensitivity, requiring approximately 100-fold higher [ PROTEIN2 for both leaf elongation and PROTEIN production by aleurone",IEPA.d117.s285
388,IEPA.d118,False,"Phorbol myristate acetate (TPA), an activator of PROTEIN1 elicited an increase of MAPK activity, but did not further influence the level of PROTEIN2 -8-enhanced MAPK activity; Nevertheless, the extent of CaMKII activation was attenuated by TPA",IEPA.d118.s286
389,IEPA.d119,True,The PROTEIN1 responsive elements conserved in cereal PROTEIN2 genes are not included in the 5'-upstream region of Rep1 or RepA,IEPA.d119.s287
390,IEPA.d120,True,"Furthermore, our 14C-acetate-labeling studies showed a 50% reduction in PROTEIN1 synthesis in the presence of either PROTEIN2 which could account for the reduction in net apoB secretion caused by incubation with these compounds",IEPA.d120.s288
391,IEPA.d121,False,"An inhibitor of PROTEIN1 Ro31-8220 (10 microM), abolished the ability of PDBu to decrease [Ca(2+)](i), without affecting the response to maximal or submaximal concentrations of PROTEIN2 ",IEPA.d121.s289
392,IEPA.d122,True,Effects of intravenously infused PROTEIN1 on insulin sensitivity and on the expression of PROTEIN2 in brown adipose tissue,IEPA.d122.s290
393,IEPA.d122,True,Centrally administered PROTEIN1 has been shown to increase insulin-stimulated glucose utilization and to favor the expression of PROTEIN2 (UCPs),IEPA.d122.s291
394,IEPA.d122,False,"To study if PROTEIN1 also has direct peripherally mediated effects on these processes, this hormone (1 mg/day) or its vehicle was infused i.v. for 4 days to lean rats and insulin-stimulated glucose utilization in skeletal muscle and adipose tissue as well as the expression of PROTEIN2 messenger RNAs (mRNAs) in brown adipose tissue were measured",IEPA.d122.s292
395,IEPA.d122,True,"I.v. PROTEIN1 infusion also favored the expression of PROTEIN2 in brown adipose tissue, either by increasing their expression or preventing the fall occurring during the pair-feeding regimen.",IEPA.d122.s293
396,IEPA.d122,False,"Relative PROTEIN1 expression levels were 100, 104, and 33 for PROTEIN 100, 191, and 125 for PROTEIN and 100, 107, and 29 for PROTEIN in ad libitum fed control rats, in PROTEIN2 treated rats and in pair-fed control rats, respectively",IEPA.d122.s294
397,IEPA.d122,False,"Relative PROTEIN expression levels were 100, 104, and 33 for PROTEIN 100, 191, and 125 for PROTEIN and 100, 107, and 29 for PROTEIN1 in ad libitum fed control rats, in PROTEIN2 treated rats and in pair-fed control rats, respectively",IEPA.d122.s294
398,IEPA.d122,False,"Relative PROTEIN expression levels were 100, 104, and 33 for PROTEIN 100, 191, and 125 for PROTEIN1 and 100, 107, and 29 for PROTEIN in ad libitum fed control rats, in PROTEIN2 treated rats and in pair-fed control rats, respectively",IEPA.d122.s294
399,IEPA.d122,False,"Relative PROTEIN expression levels were 100, 104, and 33 for PROTEIN1 100, 191, and 125 for PROTEIN and 100, 107, and 29 for PROTEIN in ad libitum fed control rats, in PROTEIN2 treated rats and in pair-fed control rats, respectively",IEPA.d122.s294
400,IEPA.d122,False,"Relative PROTEIN1 expression levels were 100, 104, and 33 for PROTEIN 100, 191, and 125 for PROTEIN and 100, 107, and 29 for PROTEIN2 in ad libitum fed control rats, in PROTEIN treated rats and in pair-fed control rats, respectively",IEPA.d122.s294
401,IEPA.d122,False,"Relative PROTEIN1 expression levels were 100, 104, and 33 for PROTEIN 100, 191, and 125 for PROTEIN2 and 100, 107, and 29 for PROTEIN in ad libitum fed control rats, in PROTEIN treated rats and in pair-fed control rats, respectively",IEPA.d122.s294
402,IEPA.d122,False,"Relative PROTEIN1 expression levels were 100, 104, and 33 for PROTEIN2 100, 191, and 125 for PROTEIN and 100, 107, and 29 for PROTEIN in ad libitum fed control rats, in PROTEIN treated rats and in pair-fed control rats, respectively",IEPA.d122.s294
403,IEPA.d122,False,"Relative PROTEIN expression levels were 100, 104, and 33 for PROTEIN 100, 191, and 125 for PROTEIN1 and 100, 107, and 29 for PROTEIN2 in ad libitum fed control rats, in PROTEIN treated rats and in pair-fed control rats, respectively",IEPA.d122.s294
404,IEPA.d122,False,"Relative PROTEIN expression levels were 100, 104, and 33 for PROTEIN1 100, 191, and 125 for PROTEIN and 100, 107, and 29 for PROTEIN2 in ad libitum fed control rats, in PROTEIN treated rats and in pair-fed control rats, respectively",IEPA.d122.s294
405,IEPA.d122,False,"Relative PROTEIN expression levels were 100, 104, and 33 for PROTEIN1 100, 191, and 125 for PROTEIN2 and 100, 107, and 29 for PROTEIN in ad libitum fed control rats, in PROTEIN treated rats and in pair-fed control rats, respectively",IEPA.d122.s294
406,IEPA.d122,True,These results suggest that the overall effect of PROTEIN1 on glucose utilization and on the expression of PROTEIN2 may be mediated through central mechanism,IEPA.d122.s295
407,IEPA.d126,False,"The expression of uterine PROTEIN and PROTEIN1 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN2 resulted in induction of the uterine PROTEIN and PROTEIN levels",IEPA.d126.s299
408,IEPA.d126,False,"The expression of uterine PROTEIN1 and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN2 resulted in induction of the uterine PROTEIN and PROTEIN levels",IEPA.d126.s299
409,IEPA.d126,False,"The expression of uterine PROTEIN and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN1 mRNA expression and exogenous administration of PROTEIN2 resulted in induction of the uterine PROTEIN and PROTEIN levels",IEPA.d126.s299
410,IEPA.d126,True,"The expression of uterine PROTEIN and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN1 resulted in induction of the uterine PROTEIN and PROTEIN2 levels",IEPA.d126.s299
411,IEPA.d126,True,"The expression of uterine PROTEIN and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN1 resulted in induction of the uterine PROTEIN2 and PROTEIN levels",IEPA.d126.s299
412,IEPA.d126,False,"The expression of uterine PROTEIN1 and PROTEIN2 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN and PROTEIN levels",IEPA.d126.s299
413,IEPA.d126,False,"The expression of uterine PROTEIN and PROTEIN1 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN2 mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN and PROTEIN levels",IEPA.d126.s299
414,IEPA.d126,False,"The expression of uterine PROTEIN and PROTEIN1 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN and PROTEIN2 levels",IEPA.d126.s299
415,IEPA.d126,False,"The expression of uterine PROTEIN and PROTEIN1 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN2 and PROTEIN levels",IEPA.d126.s299
416,IEPA.d126,False,"The expression of uterine PROTEIN1 and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN2 mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN and PROTEIN levels",IEPA.d126.s299
417,IEPA.d126,False,"The expression of uterine PROTEIN1 and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN and PROTEIN2 levels",IEPA.d126.s299
418,IEPA.d126,False,"The expression of uterine PROTEIN1 and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN2 and PROTEIN levels",IEPA.d126.s299
419,IEPA.d126,False,"The expression of uterine PROTEIN and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN1 mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN and PROTEIN2 levels",IEPA.d126.s299
420,IEPA.d126,False,"The expression of uterine PROTEIN and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN1 mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN2 and PROTEIN levels",IEPA.d126.s299
421,IEPA.d126,False,"The expression of uterine PROTEIN and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN1 and PROTEIN2 levels",IEPA.d126.s299
422,IEPA.d126,False,"These results indicate that PROTEIN gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine PROTEIN1 and PROTEIN2 mRNA may be due to increased PROTEIN levels",IEPA.d126.s300
423,IEPA.d126,True,"These results indicate that PROTEIN gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine PROTEIN and PROTEIN1 mRNA may be due to increased PROTEIN2 levels",IEPA.d126.s300
424,IEPA.d126,False,"These results indicate that PROTEIN1 gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine PROTEIN and PROTEIN2 mRNA may be due to increased PROTEIN levels",IEPA.d126.s300
425,IEPA.d126,True,"These results indicate that PROTEIN gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine PROTEIN1 and PROTEIN mRNA may be due to increased PROTEIN2 levels",IEPA.d126.s300
426,IEPA.d126,False,"These results indicate that PROTEIN1 gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine PROTEIN2 and PROTEIN mRNA may be due to increased PROTEIN levels",IEPA.d126.s300
427,IEPA.d126,False,"These results indicate that PROTEIN1 gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine PROTEIN and PROTEIN mRNA may be due to increased PROTEIN2 levels",IEPA.d126.s300
428,IEPA.d127,True, PROTEIN1 treatment of fetal guinea pig brain cultures substantially reduced the amount of PROTEIN and PROTEIN2 in the medium but had no effect on sAPPalpha,IEPA.d127.s301
429,IEPA.d127,True, PROTEIN1 treatment of fetal guinea pig brain cultures substantially reduced the amount of PROTEIN2 and PROTEIN in the medium but had no effect on sAPPalpha,IEPA.d127.s301
430,IEPA.d127,False, PROTEIN treatment of fetal guinea pig brain cultures substantially reduced the amount of PROTEIN1 and PROTEIN2 in the medium but had no effect on sAPPalpha,IEPA.d127.s301
431,IEPA.d127,False,"When this parental line was treated with PROTEIN1 PROTEIN PROTEIN and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PROTEIN2 ",IEPA.d127.s302
432,IEPA.d127,False,"When this parental line was treated with PROTEIN PROTEIN1 PROTEIN and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PROTEIN2 ",IEPA.d127.s302
433,IEPA.d127,False,"When this parental line was treated with PROTEIN PROTEIN PROTEIN1 and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PROTEIN2 ",IEPA.d127.s302
434,IEPA.d127,True,"When this parental line was treated with PROTEIN1 PROTEIN2 PROTEIN and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PROTEIN ",IEPA.d127.s302
435,IEPA.d127,True,"When this parental line was treated with PROTEIN1 PROTEIN PROTEIN2 and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PROTEIN ",IEPA.d127.s302
436,IEPA.d127,False,"When this parental line was treated with PROTEIN PROTEIN1 PROTEIN2 and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PROTEIN ",IEPA.d127.s302
437,IEPA.d128,True,"A neurotoxic fragment of PROTEIN1 Abeta 25-35, incubated in the presence of endogenous Ca2+, increased significantly the PROTEIN2 activity of normoxic brain",IEPA.d128.s303
438,IEPA.d128,True,"In its non-aggregated form, PROTEIN1 activates PROTEIN2 but in the aggregated form the enzymatic activity decreased",IEPA.d128.s304
439,IEPA.d128,True,"Thus, PROTEIN1 exerts a similar effect on the membrane-bound PROTEIN2 from normoxic brain or subjected to ischemia reperfusion injury",IEPA.d128.s305
440,IEPA.d128,True,Ischemia-reperfusion injury had no effect on PROTEIN1 evoked alterations of synaptic plasma membrane-bound PROTEIN2 ,IEPA.d128.s306
441,IEPA.d129,False,"Sympathetic inhibition, PROTEIN1 and PROTEIN2 subtype expression in normal fasting rats",IEPA.d129.s307
442,IEPA.d129,False,"To further investigate neural effects on PROTEIN1 and PROTEIN2 (UCPs), we studied in vivo perturbations intended to block adrenergic input to peripheral tissues",IEPA.d129.s308
443,IEPA.d129,False,"We examined plasma PROTEIN1 PROTEIN2 mRNA, and adipose and muscle PROTEIN subtype mRNA in rats treated with alpha-methyl-p-tyrosine methyl ester (AMPT-ME), which inhibits catecholamine synthesis and 6-hydroxydopamine (6HDA), which is toxic to catecholinergic nerve terminals but, unlike AMPT-ME, does not enter the central nervous system",IEPA.d129.s309
444,IEPA.d129,False,"We examined plasma PROTEIN1 PROTEIN mRNA, and adipose and muscle PROTEIN2 subtype mRNA in rats treated with alpha-methyl-p-tyrosine methyl ester (AMPT-ME), which inhibits catecholamine synthesis and 6-hydroxydopamine (6HDA), which is toxic to catecholinergic nerve terminals but, unlike AMPT-ME, does not enter the central nervous system",IEPA.d129.s309
445,IEPA.d129,False,"We examined plasma PROTEIN PROTEIN1 mRNA, and adipose and muscle PROTEIN2 subtype mRNA in rats treated with alpha-methyl-p-tyrosine methyl ester (AMPT-ME), which inhibits catecholamine synthesis and 6-hydroxydopamine (6HDA), which is toxic to catecholinergic nerve terminals but, unlike AMPT-ME, does not enter the central nervous system",IEPA.d129.s309
446,IEPA.d129,False,"Intraperitoneal 6HDA, 100 mg/kg, as a single dose at 1800, increased plasma PROTEIN1 approximately twofold after 18-20 h, increased IBAT (but not epididymal fat) PROTEIN2 mRNA by two- to threefold, and decreased IBAT PROTEIN mRNA to 30-40% of control",IEPA.d129.s310
447,IEPA.d129,False,"Intraperitoneal 6HDA, 100 mg/kg, as a single dose at 1800, increased plasma PROTEIN1 approximately twofold after 18-20 h, increased IBAT (but not epididymal fat) PROTEIN mRNA by two- to threefold, and decreased IBAT PROTEIN2 mRNA to 30-40% of control",IEPA.d129.s310
448,IEPA.d129,False,"Intraperitoneal 6HDA, 100 mg/kg, as a single dose at 1800, increased plasma PROTEIN approximately twofold after 18-20 h, increased IBAT (but not epididymal fat) PROTEIN1 mRNA by two- to threefold, and decreased IBAT PROTEIN2 mRNA to 30-40% of control",IEPA.d129.s310
449,IEPA.d129,False,"However, the in vivo modulation of PROTEIN1 and PROTEIN2 appears complex and, beyond a causal effect of SNA per se, may depend on concurrent changes in plasma insulin, glucose, and circulatory hemodynamics",IEPA.d129.s311
450,IEPA.d130,True, PROTEIN1 beta peptide 25-35 modulates hydrolysis of phosphoinositides by membrane PROTEIN2 of adult brain cortex,IEPA.d130.s312
451,IEPA.d130,True,"Fresh-water-soluble PROTEIN1 25-35 activated PROTEIN2 in SPM markedly by two- to threefold, but this effect was absent in the presence of 2 mM CaCl2",IEPA.d130.s313
452,IEPA.d130,False,"Moreover, PROTEIN1 25-35 had no effect on basal PROTEIN activity and cytosolic PROTEIN and PROTEIN2 ",IEPA.d130.s314
453,IEPA.d130,False,"Moreover, PROTEIN 25-35 had no effect on basal PROTEIN activity and cytosolic PROTEIN1 and PROTEIN2 ",IEPA.d130.s314
454,IEPA.d130,False,"Moreover, PROTEIN 25-35 had no effect on basal PROTEIN1 activity and cytosolic PROTEIN and PROTEIN2 ",IEPA.d130.s314
455,IEPA.d130,False,"Moreover, PROTEIN1 25-35 had no effect on basal PROTEIN activity and cytosolic PROTEIN2 and PROTEIN ",IEPA.d130.s314
456,IEPA.d130,False,"Moreover, PROTEIN1 25-35 had no effect on basal PROTEIN2 activity and cytosolic PROTEIN and PROTEIN ",IEPA.d130.s314
457,IEPA.d130,False,"Moreover, PROTEIN 25-35 had no effect on basal PROTEIN1 activity and cytosolic PROTEIN2 and PROTEIN ",IEPA.d130.s314
458,IEPA.d130,True,The aggregated form of PROTEIN1 25-35 significantly inhibited PROTEIN2 only in the presence of endogenous CaCl2,IEPA.d130.s315
459,IEPA.d131,True," PROTEIN1 stimulates tyrosine phosphorylation by activation of PROTEIN2 in the rat smooth muscle cell line, A-10",IEPA.d131.s316
460,IEPA.d131,True,"The PROTEIN1 (PKC) inhibitors: staurosporine, H7 and GF109203X are able to block the PROTEIN2 stimulated phosphorylation",IEPA.d131.s317
461,IEPA.d131,True,"These results indicate that PROTEIN1 is upstream of the phosphorylation, a motion which is supported by the fact that the PROTEIN2 stimulated phosphorylation was downregulated by phorbol esters",IEPA.d131.s318
462,IEPA.d132,True,The effects of the fluorinated analogues were evaluated on inhibition of cress seed germination and inhibition of PROTEIN1 inducible PROTEIN2 induction in embryoless barley half-seeds,IEPA.d132.s319
463,IEPA.d132,False,"(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited PROTEIN1 inducible PROTEIN induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of PROTEIN2 production",IEPA.d132.s320
464,IEPA.d132,False,"(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited PROTEIN inducible PROTEIN1 induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of PROTEIN2 production",IEPA.d132.s320
465,IEPA.d132,True,"(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited PROTEIN1 inducible PROTEIN2 induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of PROTEIN production",IEPA.d132.s320
466,IEPA.d133,False,"Neurotransmitters and hormones, such as arginine vasopressin (AVP) and bombesin, evoke frequency-modulated repetitive Ca2+ transients in PROTEIN1 secreting HIT-T15 cells by binding to receptors linked to PROTEIN2 (PLC)",IEPA.d133.s321
467,IEPA.d134,True,"Isolation and characterization of gibbestatin B, an inhibitor of PROTEIN1 induced expression of PROTEIN2 and gibbestatin C from streptomycetaes",IEPA.d134.s322
468,IEPA.d137,True,We previously showed that PROTEIN1 (AVP) stimulates heat shock protein 27 (HSP27) induction through PROTEIN2 activation in aortic smooth muscle A10 cells,IEPA.d137.s325
469,IEPA.d137,True,"Calphostin C and ET-18-OCH(3), inhibitors of PROTEIN1 reduced the phosphorylation of p38 MAP kinase by PROTEIN2 ",IEPA.d137.s326
470,IEPA.d138,False," PROTEIN1 like signaling in yeast: modulation of protein phosphatase 2A, protein kinase A, cAMP-specific phosphodiesterase, and glycosyl-phosphatidylinositol-specific PROTEIN2 activities",IEPA.d138.s327
471,IEPA.d138,False,"In addition, PROTEIN1 (GPI-PLC), which in isolated rat adipocytes is activated by PROTEIN was stimulated to up to 5-fold by glucose and 10-fold by glucose plus PROTEIN in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the PROTEIN2 ",IEPA.d138.s328
472,IEPA.d138,False,"In addition, PROTEIN (GPI-PLC), which in isolated rat adipocytes is activated by PROTEIN was stimulated to up to 5-fold by glucose and 10-fold by glucose plus PROTEIN1 in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the PROTEIN2 ",IEPA.d138.s328
473,IEPA.d138,False,"In addition, PROTEIN (GPI-PLC), which in isolated rat adipocytes is activated by PROTEIN1 was stimulated to up to 5-fold by glucose and 10-fold by glucose plus PROTEIN in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the PROTEIN2 ",IEPA.d138.s328
474,IEPA.d138,True,"In addition, PROTEIN1 (GPI-PLC), which in isolated rat adipocytes is activated by PROTEIN was stimulated to up to 5-fold by glucose and 10-fold by glucose plus PROTEIN2 in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the PROTEIN ",IEPA.d138.s328
475,IEPA.d138,True,"In addition, PROTEIN1 (GPI-PLC), which in isolated rat adipocytes is activated by PROTEIN2 was stimulated to up to 5-fold by glucose and 10-fold by glucose plus PROTEIN in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the PROTEIN ",IEPA.d138.s328
476,IEPA.d138,False,"In addition, PROTEIN (GPI-PLC), which in isolated rat adipocytes is activated by PROTEIN1 was stimulated to up to 5-fold by glucose and 10-fold by glucose plus PROTEIN2 in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the PROTEIN ",IEPA.d138.s328
477,IEPA.d138,True, PROTEIN1 was most pronouncedly stimulated by authentic human PROTEIN2 compared to various insulin analogues and insulin-like growth factor I,IEPA.d138.s329
478,IEPA.d138,False,"As the PROTEIN1 reaction is rate limiting, the efficiency of the two-step anchor cleavage was significantly increased when PROTEIN2 was present together with glucose as compared to glucose alone",IEPA.d138.s330
479,IEPA.d138,True,"The PROTEIN1 concentrations effective in modulating PP2A, PKA, cAMP-PDE, and PROTEIN2 activities correlate well with those required for half-saturation of the specific binding sites as well as for stimulation of protein phosphorylation and glycogen accumulation",IEPA.d138.s331
480,IEPA.d138,False,"The data suggest that mammalian PROTEIN1 sensitive cells and yeast share (part of) the key regulatory mechanism (consisting of PP2A, PKA, cAMP-PDE, and PROTEIN2 involved in the transduction of the PROTEIN signal from the respective receptor systems to glycogen synthase and phosphorylase",IEPA.d138.s332
481,IEPA.d138,False,"The data suggest that mammalian PROTEIN1 sensitive cells and yeast share (part of) the key regulatory mechanism (consisting of PP2A, PKA, cAMP-PDE, and PROTEIN involved in the transduction of the PROTEIN2 signal from the respective receptor systems to glycogen synthase and phosphorylase",IEPA.d138.s332
482,IEPA.d138,True,"The data suggest that mammalian PROTEIN sensitive cells and yeast share (part of) the key regulatory mechanism (consisting of PP2A, PKA, cAMP-PDE, and PROTEIN1 involved in the transduction of the PROTEIN2 signal from the respective receptor systems to glycogen synthase and phosphorylase",IEPA.d138.s332
483,IEPA.d139,False, PROTEIN1 and PROTEIN2 (1 and 2) mRNA levels were determined by reverse transcription-polymerase chain reaction (RT-PCR) methodology in adipose tissue and gastrocnemius muscle,IEPA.d139.s333
484,IEPA.d139,False,"A negative correlation between WAT O2 consumption and PROTEIN1 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle PROTEIN2 expression, as well as for plasma PROTEIN and WAT PROTEIN expression",IEPA.d139.s334
485,IEPA.d139,False,"A negative correlation between WAT O2 consumption and PROTEIN expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle PROTEIN1 expression, as well as for plasma PROTEIN2 and WAT PROTEIN expression",IEPA.d139.s334
486,IEPA.d139,False,"A negative correlation between WAT O2 consumption and PROTEIN expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle PROTEIN1 expression, as well as for plasma PROTEIN and WAT PROTEIN2 expression",IEPA.d139.s334
487,IEPA.d139,False,"A negative correlation between WAT O2 consumption and PROTEIN1 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle PROTEIN expression, as well as for plasma PROTEIN2 and WAT PROTEIN expression",IEPA.d139.s334
488,IEPA.d139,False,"A negative correlation between WAT O2 consumption and PROTEIN1 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle PROTEIN expression, as well as for plasma PROTEIN and WAT PROTEIN2 expression",IEPA.d139.s334
489,IEPA.d139,False,"A negative correlation between WAT O2 consumption and PROTEIN expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle PROTEIN expression, as well as for plasma PROTEIN1 and WAT PROTEIN2 expression",IEPA.d139.s334
490,IEPA.d140,True, PROTEIN1 (AVP) and lysophosphatidic acid (LPA) have been shown to stimulate PROTEIN2 (PKC) and mitogen-activated protein (MAP) kinases and the proliferation of vascular smooth muscle cells,IEPA.d140.s335
491,IEPA.d140,True,"However, PROTEIN1 induced activation of RSK2, a downstream substrate of ERK1 and ERK2, was PROTEIN2 dependent and PI 3-kinase-independent",IEPA.d140.s336
492,IEPA.d140,True, PROTEIN1 was necessary in PROTEIN2 but not in LPA-induced activation of p70 S6K,IEPA.d140.s337
493,IEPA.d141,True,Tolbutamide and diazoxide modulate PROTEIN1 linked Ca(2+) signaling and PROTEIN2 secretion in beta-cells,IEPA.d141.s338
494,IEPA.d141,True,"We examined whether tolbutamide and diazoxide, which close or open ATP-sensitive K(+) channels (K(ATP) channels), respectively, interact with PROTEIN linked Ca(2+) signals in HIT-T15 and mouse beta-cells and with PROTEIN1 linked PROTEIN2 secretion from HIT-T15 cells",IEPA.d141.s339
495,IEPA.d141,False,"We examined whether tolbutamide and diazoxide, which close or open ATP-sensitive K(+) channels (K(ATP) channels), respectively, interact with PROTEIN1 linked Ca(2+) signals in HIT-T15 and mouse beta-cells and with PROTEIN linked PROTEIN2 secretion from HIT-T15 cells",IEPA.d141.s339
496,IEPA.d141,False,"We examined whether tolbutamide and diazoxide, which close or open ATP-sensitive K(+) channels (K(ATP) channels), respectively, interact with PROTEIN1 linked Ca(2+) signals in HIT-T15 and mouse beta-cells and with PROTEIN2 linked PROTEIN secretion from HIT-T15 cells",IEPA.d141.s339
497,IEPA.d141,True,"Thus tolbutamide and diazoxide regulate both PROTEIN1 linked Ca(2+) signaling and PROTEIN2 secretion from pancreatic beta-cells by modulating K(ATP) channels, thereby determining voltage-sensitive Ca(2+) influx",IEPA.d141.s340
498,IEPA.d143,True, PROTEIN1 central injections to intact animals stimulated PROTEIN2 synthesis and secretion without changing of islets area,IEPA.d143.s343
499,IEPA.d143,True,"Thus, PROTEIN1 administration stimulates PROTEIN2 synthesis and secretion in intact and diabetic animals and this effect is more expressed with central injections",IEPA.d143.s344
500,IEPA.d144,True,Hypothalamic PROTEIN1 and its neuroendocrine regulation by PROTEIN2 ,IEPA.d144.s345
501,IEPA.d146,True,Ca2+ signalling in rat vascular smooth muscle cells: a role for PROTEIN1 at physiological vasoconstrictor concentrations of PROTEIN2 ,IEPA.d146.s351
502,IEPA.d146,False,"The PROTEIN1 (PKC) activator 4beta-phorbol 12-myristate 13-acetate (PMA, 100 pM to 200 nM), also stimulated Ca2+ spiking and this effect was additive with a submaximal concentration of PROTEIN2 (50 pM)",IEPA.d146.s352
503,IEPA.d146,True,The PROTEIN1 Ro-31-8220 (1 microM) and calphostin C (250 nM) completely blocked the stimulation of Ca2+ spiking by either PMA or PROTEIN2 ,IEPA.d146.s353
504,IEPA.d146,True,Time-dependent redistribution of PROTEIN1 -delta and -epsilon isoforms between the membrane and cytosolic fractions occurred in response to 100 pM PROTEIN2 ,IEPA.d146.s354
505,IEPA.d146,False,"Pretreatment for 24 h with 1 microM PMA downregulated expression of PROTEIN1 and -delta, but not PROTEIN2 and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM PROTEIN ",IEPA.d146.s355
506,IEPA.d146,False,"Pretreatment for 24 h with 1 microM PMA downregulated expression of PROTEIN1 and -delta, but not PROTEIN and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM PROTEIN2 ",IEPA.d146.s355
507,IEPA.d146,False,"Pretreatment for 24 h with 1 microM PMA downregulated expression of PROTEIN and -delta, but not PROTEIN1 and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM PROTEIN2 ",IEPA.d146.s355
508,IEPA.d146,True,We conclude that PROTEIN1 activation is a necessary step in the signal transduction pathway linking low concentrations of PROTEIN2 to Ca2+ spiking in A7r5 cells,IEPA.d146.s356
509,IEPA.d147,False,Ten PROTEIN1 have been assayed for their ability to phosphorylate in vitro the PROTEIN2 (25-242) (rbPrP),IEPA.d147.s357
510,IEPA.d147,True,With regard to PROTEIN1 phosphorylation occurs at Ser 154 with a stoichiometry of about 0.1 mol phosphate/mol PROTEIN2 which is doubled by mild heat treatment of PROTEIN ,IEPA.d147.s358
511,IEPA.d147,False,With regard to PROTEIN phosphorylation occurs at Ser 154 with a stoichiometry of about 0.1 mol phosphate/mol PROTEIN1 which is doubled by mild heat treatment of PROTEIN2 ,IEPA.d147.s358
512,IEPA.d147,False,With regard to PROTEIN1 phosphorylation occurs at Ser 154 with a stoichiometry of about 0.1 mol phosphate/mol PROTEIN which is doubled by mild heat treatment of PROTEIN2 ,IEPA.d147.s358
513,IEPA.d148,False,In vivo effects of CGP-12177 on the expression of PROTEIN1 and PROTEIN2 genes in mouse brown and white adipose tissues,IEPA.d148.s359
514,IEPA.d148,False,"OBJECTIVE: To assess the effect of chronic treatment with CGP-12177 a beta3-adrenergic receptor (AR) agonist with beta2/beta1-AR antagonist action, on the expression of the PROTEIN1 gene and of genes coding for PROTEIN2 (ucp1, ucp2 and ucp3) in brown and white adipose tissues",IEPA.d148.s360
515,IEPA.d148,False,"CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain PROTEIN1 genes and the PROTEIN2 gene can be achieved, and suggest that adrenergic regulation of the PROTEIN gene and of genes of the PROTEIN family in adipose tissues is the result of complex interactions between the different beta-AR pathways",IEPA.d148.s361
516,IEPA.d148,False,"CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain PROTEIN1 genes and the PROTEIN gene can be achieved, and suggest that adrenergic regulation of the PROTEIN gene and of genes of the PROTEIN2 family in adipose tissues is the result of complex interactions between the different beta-AR pathways",IEPA.d148.s361
517,IEPA.d148,False,"CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain PROTEIN1 genes and the PROTEIN gene can be achieved, and suggest that adrenergic regulation of the PROTEIN2 gene and of genes of the PROTEIN family in adipose tissues is the result of complex interactions between the different beta-AR pathways",IEPA.d148.s361
518,IEPA.d148,False,"CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain PROTEIN genes and the PROTEIN1 gene can be achieved, and suggest that adrenergic regulation of the PROTEIN gene and of genes of the PROTEIN2 family in adipose tissues is the result of complex interactions between the different beta-AR pathways",IEPA.d148.s361
519,IEPA.d148,False,"CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain PROTEIN genes and the PROTEIN1 gene can be achieved, and suggest that adrenergic regulation of the PROTEIN2 gene and of genes of the PROTEIN family in adipose tissues is the result of complex interactions between the different beta-AR pathways",IEPA.d148.s361
520,IEPA.d148,False,"CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain PROTEIN genes and the PROTEIN gene can be achieved, and suggest that adrenergic regulation of the PROTEIN1 gene and of genes of the PROTEIN2 family in adipose tissues is the result of complex interactions between the different beta-AR pathways",IEPA.d148.s361
521,IEPA.d149,True,"Furthermore, in SN-56/OBR cells both CNTF and PROTEIN1 produce changes in neurotransmitter and neuropeptide phenotype characteristic of cholinergic neurons, such as an increase in choline acetyltransferase and vasoactive intestinal polypeptide, and a decrease in PROTEIN2 expression",IEPA.d149.s362
522,IEPA.d150,True,Possible central nervous system (CNS) mechanisms could mediate these responses in that leptin receptors are located on hypothalamic neurons that coexpress PROTEIN1 (NPY) or proopiomelanocortin (POMC) and both peptides that have been implicated as mediators of the CNS action of PROTEIN2 ,IEPA.d150.s363
523,IEPA.d150,True, PROTEIN1 has been demonstrated to decrease or down regulate PROTEIN2 expression and increase POMC expression,IEPA.d150.s364
524,IEPA.d151,True,Relationship among PROTEIN1 PROTEIN2 and galanin in young women and in postmenopausal women [see comments],IEPA.d151.s365
525,IEPA.d151,False,"OBJECTIVE: To determine whether hormonal status may affect PROTEIN1 (NPY), galanin, and PROTEIN2 release in postmenopausal women and in young women",IEPA.d151.s366
526,IEPA.d151,False,CONCLUSIONS: Our results suggest that the differences is plasma PROTEIN1 PROTEIN and galanin between postmenopausal women and young women may be related to body mass index rather than to differences in hormonal status and that the higher PROTEIN2 levels in both lean and obese postmenopausal women than in young women indicate that factors other than body mass index may be involved,IEPA.d151.s367
527,IEPA.d151,False,CONCLUSIONS: Our results suggest that the differences is plasma PROTEIN PROTEIN1 and galanin between postmenopausal women and young women may be related to body mass index rather than to differences in hormonal status and that the higher PROTEIN2 levels in both lean and obese postmenopausal women than in young women indicate that factors other than body mass index may be involved,IEPA.d151.s367
528,IEPA.d151,False,CONCLUSIONS: Our results suggest that the differences is plasma PROTEIN1 PROTEIN2 and galanin between postmenopausal women and young women may be related to body mass index rather than to differences in hormonal status and that the higher PROTEIN levels in both lean and obese postmenopausal women than in young women indicate that factors other than body mass index may be involved,IEPA.d151.s367
529,IEPA.d152,False,"We examined for the first time in young men effects of intravenous injections of PROTEIN1 (4x50 or 100 microg, n = 9 and 11, respectively, at 22.00, 23.00, 24.00 and 01.00 compared to saline) on the sleep electroencephalogram (EEG; recorded from 23.00 to 07.00) and nocturnal secretion of adrenocorticotrophic hormone (ACTH), cortisol, growth hormone (GH), prolactin and PROTEIN2 ",IEPA.d152.s368
530,IEPA.d153,True,"Interestingly, both 5-HT and PROTEIN1 modulate the action of PROTEIN2 which may form a part of a common output pathway for the expression of appetite",IEPA.d153.s369
531,IEPA.d154,True,"The glycosyl-phosphatidylinositol anchored protein, membrane dipeptidase (EC 3.4.13.19) is released from the surface of 3T3-L1 adipocytes in response to PROTEIN1 treatment through the action of a PROTEIN2 ",IEPA.d154.s370
532,IEPA.d154,False,"Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific PROTEIN1 it was not released upon PROTEIN2 treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to PROTEIN stimulated release",IEPA.d154.s371
533,IEPA.d154,False,"Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific PROTEIN it was not released upon PROTEIN1 treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to PROTEIN2 stimulated release",IEPA.d154.s371
534,IEPA.d154,False,"Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific PROTEIN1 it was not released upon PROTEIN treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to PROTEIN2 stimulated release",IEPA.d154.s371
535,IEPA.d155,False,"However, neither progesterone nor PROTEIN1 increased phosphotyrosine on PROTEIN2 ",IEPA.d155.s372
536,IEPA.d156,True," PROTEIN1 is a satiety factor which acts within the hypothalamus to decrease the levels of several neuropeptides stimulating food intake (among them, PROTEIN2 [NPY]), while increasing those that inhibit food intake",IEPA.d156.s373
537,IEPA.d157,True,"We have studied the effects of neomycin, a potent inhibitor of inositol phospholipid-specific phospholipase C (PLC), on the germination of rice seed and the PROTEIN1 induced expression of PROTEIN2 in the aleurone layer and the scutellar tissues",IEPA.d157.s374
538,IEPA.d157,True,"It was shown that, in the absence of exogenous Ca2+, neomycin markedly reduced the germination speed and seedling growth of rice seeds and inhibited the PROTEIN1 induced expression of PROTEIN2 in both secretory tissues",IEPA.d157.s375
539,IEPA.d157,True,These results strongly suggest that the phosphoinositide-Ca2+ signal transduction pathway may play an important role in the PROTEIN1 induced expression of PROTEIN2 molecules closely related to the germination processes of rice seed,IEPA.d157.s376
540,IEPA.d158,False, PROTEIN1 PROTEIN2 opposing effects on appetitive and consummatory ingestive behavior and sexual behavior,IEPA.d158.s377
541,IEPA.d158,False,Many studies have indicated that PROTEIN1 (NPY) stimulates and PROTEIN2 inhibits food intake,IEPA.d158.s378
542,IEPA.d158,False,"In line with this, intracerebroventricular injection of PROTEIN1 (10 microg) stimulated and PROTEIN2 (10 microg) inhibited intake of a sucrose solution when female rats were required to obtain the solution from a bottle",IEPA.d158.s379
543,IEPA.d158,False,"However, PROTEIN1 inhibited and PROTEIN2 stimulated intake if the solution was infused intraorally",IEPA.d158.s380
544,IEPA.d158,False,"Thus PROTEIN1 stimulates the responses used to obtain food but inhibits those used to consume food, and PROTEIN2 has the opposite effects",IEPA.d158.s381
545,IEPA.d159,True,"In the fasting state PROTEIN1 expression correlated inversely with body mass index (r = -0.45; P = 0.026), percent body fat (r = -0.41; P = 0.05), plasma insulin (r = -0.47; P = 0.02), epigastric venous fatty acids (r = -0.45; P = 0.04), and PROTEIN2 (r = -0.50; P = 0.018)",IEPA.d159.s382
546,IEPA.d159,True, PROTEIN1 expression remained inversely related with plasma PROTEIN2 after controlling for percent body (r = -0.45; P = 0.038),IEPA.d159.s383
547,IEPA.d159,True,"In conclusion, 1) PROTEIN1 messenger ribonucleic acid expression in sc adipose tissue is inversely related to adiposity and independently linked to local plasma PROTEIN2 levels; and 2) PROTEIN expression is not acutely regulated by food intake, insulin, or fatty acids",IEPA.d159.s384
548,IEPA.d159,False,"In conclusion, 1) PROTEIN messenger ribonucleic acid expression in sc adipose tissue is inversely related to adiposity and independently linked to local plasma PROTEIN1 levels; and 2) PROTEIN2 expression is not acutely regulated by food intake, insulin, or fatty acids",IEPA.d159.s384
549,IEPA.d159,False,"In conclusion, 1) PROTEIN1 messenger ribonucleic acid expression in sc adipose tissue is inversely related to adiposity and independently linked to local plasma PROTEIN levels; and 2) PROTEIN2 expression is not acutely regulated by food intake, insulin, or fatty acids",IEPA.d159.s384
550,IEPA.d160,False,"Thus, highly expressed in human adipocytes, the Y(1) receptor sustains the strong antilipolytic effect of PROTEIN1 and exerts a positive action on PROTEIN2 secretion",IEPA.d160.s385
551,IEPA.d161,False,"Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, PROTEIN PROTEIN1 and PROTEIN2 and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion",IEPA.d161.s386
552,IEPA.d161,False,"Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, PROTEIN1 PROTEIN and PROTEIN2 and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion",IEPA.d161.s386
553,IEPA.d161,False,"Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, PROTEIN1 PROTEIN2 and PROTEIN and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion",IEPA.d161.s386
554,IEPA.d161,False,"Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, PROTEIN PROTEIN1 and PROTEIN2 and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia",IEPA.d161.s387
555,IEPA.d161,False,"Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, PROTEIN1 PROTEIN2 and PROTEIN and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia",IEPA.d161.s387
556,IEPA.d161,False,"Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, PROTEIN1 PROTEIN and PROTEIN2 and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia",IEPA.d161.s387
557,IEPA.d161,False,"Marked increases in FAT/CD36 (724+/-18%; P < 0.05), PPAR-gamma2 (200+/-8%; P < 0.05), PROTEIN1 (110+/-13%; P < 0.05), PROTEIN (120+/-7%; P < 0.05), PROTEIN2 (80+/-5%; P < 0.05), and TNF-alpha mRNA (130+/-12%; P < 0.05) were observed in comparison with pretreatment levels, whereas there was no change after saline infusion",IEPA.d161.s388
558,IEPA.d161,False,"Marked increases in FAT/CD36 (724+/-18%; P < 0.05), PPAR-gamma2 (200+/-8%; P < 0.05), PROTEIN (110+/-13%; P < 0.05), PROTEIN1 (120+/-7%; P < 0.05), PROTEIN2 (80+/-5%; P < 0.05), and TNF-alpha mRNA (130+/-12%; P < 0.05) were observed in comparison with pretreatment levels, whereas there was no change after saline infusion",IEPA.d161.s388
559,IEPA.d161,False,"Marked increases in FAT/CD36 (724+/-18%; P < 0.05), PPAR-gamma2 (200+/-8%; P < 0.05), PROTEIN1 (110+/-13%; P < 0.05), PROTEIN2 (120+/-7%; P < 0.05), PROTEIN (80+/-5%; P < 0.05), and TNF-alpha mRNA (130+/-12%; P < 0.05) were observed in comparison with pretreatment levels, whereas there was no change after saline infusion",IEPA.d161.s388
560,IEPA.d161,False,"These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, PROTEIN1 PROTEIN2 PROTEIN and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins",IEPA.d161.s389
561,IEPA.d161,False,"These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, PROTEIN PROTEIN1 PROTEIN2 and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins",IEPA.d161.s389
562,IEPA.d161,False,"These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, PROTEIN1 PROTEIN PROTEIN2 and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins",IEPA.d161.s389
563,IEPA.d162,False,"We previously reported that adiposity and serum PROTEIN1 levels increase with age in male F-344xBN rats and that when physiological levels of serum PROTEIN are manipulated by fasting, there is a corresponding reciprocal change in hypothalamic PROTEIN2 (NPY) mRNA in young rats, but there are no changes in older rats",IEPA.d162.s390
564,IEPA.d162,False,"We previously reported that adiposity and serum PROTEIN levels increase with age in male F-344xBN rats and that when physiological levels of serum PROTEIN1 are manipulated by fasting, there is a corresponding reciprocal change in hypothalamic PROTEIN2 (NPY) mRNA in young rats, but there are no changes in older rats",IEPA.d162.s390
565,IEPA.d162,False,"We previously reported that adiposity and serum PROTEIN1 levels increase with age in male F-344xBN rats and that when physiological levels of serum PROTEIN2 are manipulated by fasting, there is a corresponding reciprocal change in hypothalamic PROTEIN (NPY) mRNA in young rats, but there are no changes in older rats",IEPA.d162.s390
566,IEPA.d162,True,These findings suggest that the regulation of hypothalamic PROTEIN1 mRNA by PROTEIN2 may be impaired with age,IEPA.d162.s391
567,IEPA.d162,False,"We examined daily food consumption, body weight, whole-body oxygen consumption, serum PROTEIN1 and PROTEIN2 mRNA in the hypothalamus",IEPA.d162.s392
568,IEPA.d162,True," PROTEIN1 infusion diminished hypothalamic PROTEIN2 levels by nearly 50% compared with pair-fed young rats, whereas there were no changes in the hypothalamic PROTEIN mRNA levels in senescent rats",IEPA.d162.s393
569,IEPA.d162,False," PROTEIN1 infusion diminished hypothalamic PROTEIN levels by nearly 50% compared with pair-fed young rats, whereas there were no changes in the hypothalamic PROTEIN2 mRNA levels in senescent rats",IEPA.d162.s393
570,IEPA.d162,False," PROTEIN infusion diminished hypothalamic PROTEIN1 levels by nearly 50% compared with pair-fed young rats, whereas there were no changes in the hypothalamic PROTEIN2 mRNA levels in senescent rats",IEPA.d162.s393
571,IEPA.d162,False,These diminished responses to PROTEIN1 were associated with and may be the result of an impaired suppression of hypothalamic PROTEIN2 mRNA levels,IEPA.d162.s394
572,IEPA.d163,False,C75 inhibited expression of the prophagic signal PROTEIN1 in the hypothalamus and acted in a PROTEIN2 independent manner that appears to be mediated by malonyl-coenzyme A,IEPA.d163.s395
573,IEPA.d164,False,"The aims of this study were: (1) to assess the effects of maternal undernutrition during pregnancy on adult offspring with regard to growth, body composition and plasma levels of glucose, PROTEIN1 and corticosterone, and (2) to investigate whether PROTEIN2 treatment early in life could ameliorate the adverse effects of food restriction in utero",IEPA.d164.s396
574,IEPA.d165,True,Interactions between PROTEIN1 and PROTEIN2 affecting lipid mobilization in adipose tissue,IEPA.d165.s397
575,IEPA.d165,False,The aim of the current investigations was focused on the study of the involvement of PROTEIN1 and PROTEIN2 in lipid mobilization,IEPA.d165.s398
576,IEPA.d165,False,The lipolytic rate was assessed through glycerol release after incubation with PROTEIN1 and PROTEIN2 at concentrations ranging from 10(-6) to 10(-12) M in isolated adipocytes obtained from female rats,IEPA.d165.s399
577,IEPA.d165,False,"At equimolar concentrations of PROTEIN1 and PROTEIN2 (10(-12) to 10(-6) M) the observed lipolytic activity is comparable to the basal lipolytic activity, except at a concentration of 10(-9) M where upon a significant increase in lipolysis is observed",IEPA.d165.s400
578,IEPA.d165,True,"Summing up, new evidence suggests that PROTEIN1 and PROTEIN2 may interact in a homeostatic loop to regulate body-fat mass and energy balance not only at the central nervous system level, but also directly at the adipocyte level",IEPA.d165.s401
579,IEPA.d166,False,The PROTEIN1 specific inhibitor Go-6983 further enhanced the inhibitory effect of VACM-1 on PROTEIN2 stimulated cAMP production,IEPA.d166.s402
580,IEPA.d168,True,Involvement of thyroid hormones in the effect of intracerebroventricular PROTEIN1 infusion on PROTEIN2 expression in rat muscle,IEPA.d168.s404
581,IEPA.d168,False,"A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking PROTEIN induced hyperphagia, produced a marked decrease in the expression of muscle PROTEIN1 (UCP-3), whereas ICV infusion of PROTEIN prevented such a decrease in PROTEIN2 ",IEPA.d168.s405
582,IEPA.d168,False,"A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking PROTEIN1 induced hyperphagia, produced a marked decrease in the expression of muscle PROTEIN (UCP-3), whereas ICV infusion of PROTEIN prevented such a decrease in PROTEIN2 ",IEPA.d168.s405
583,IEPA.d168,True,"A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking PROTEIN induced hyperphagia, produced a marked decrease in the expression of muscle PROTEIN (UCP-3), whereas ICV infusion of PROTEIN1 prevented such a decrease in PROTEIN2 ",IEPA.d168.s405
584,IEPA.d168,True,"A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking PROTEIN1 induced hyperphagia, produced a marked decrease in the expression of muscle PROTEIN2 (UCP-3), whereas ICV infusion of PROTEIN prevented such a decrease in PROTEIN ",IEPA.d168.s405
585,IEPA.d168,False,"A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking PROTEIN induced hyperphagia, produced a marked decrease in the expression of muscle PROTEIN1 (UCP-3), whereas ICV infusion of PROTEIN2 prevented such a decrease in PROTEIN ",IEPA.d168.s405
586,IEPA.d168,False,"A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking PROTEIN1 induced hyperphagia, produced a marked decrease in the expression of muscle PROTEIN (UCP-3), whereas ICV infusion of PROTEIN2 prevented such a decrease in PROTEIN ",IEPA.d168.s405
587,IEPA.d168,False,"To further substantiate an involvement of thyroid hormones in the effect of PROTEIN1 on muscle PROTEIN expression, hypothyroid rats were ICV infused with PROTEIN2 or vehicle",IEPA.d168.s406
588,IEPA.d168,True,"To further substantiate an involvement of thyroid hormones in the effect of PROTEIN1 on muscle PROTEIN2 expression, hypothyroid rats were ICV infused with PROTEIN or vehicle",IEPA.d168.s406
589,IEPA.d168,False,"To further substantiate an involvement of thyroid hormones in the effect of PROTEIN on muscle PROTEIN1 expression, hypothyroid rats were ICV infused with PROTEIN2 or vehicle",IEPA.d168.s406
590,IEPA.d168,True,"It was observed that in hypothyroid rats, ICV PROTEIN1 was unable to maintain muscle PROTEIN2 expression at values measured in ad libitum fed controls",IEPA.d168.s407
591,IEPA.d168,False,"These results suggest that central PROTEIN1 stimulates T3 production via an activation of T4 to T3 conversion, and that this stimulation could be responsible for the effect of PROTEIN2 on muscle PROTEIN expression",IEPA.d168.s408
592,IEPA.d168,False,"These results suggest that central PROTEIN1 stimulates T3 production via an activation of T4 to T3 conversion, and that this stimulation could be responsible for the effect of PROTEIN on muscle PROTEIN2 expression",IEPA.d168.s408
593,IEPA.d168,True,"These results suggest that central PROTEIN stimulates T3 production via an activation of T4 to T3 conversion, and that this stimulation could be responsible for the effect of PROTEIN1 on muscle PROTEIN2 expression",IEPA.d168.s408
594,IEPA.d169,False,"The body mass index (BMI), PROTEIN1 plasma PROTEIN2 (NPY), serotonin, thyroxine (T4), triiodothyronine (T3) and reverse triiodothyronine (rT3) in serum were evaluated for each subject",IEPA.d169.s409
595,IEPA.d171,False," PROTEIN1 (PLC) activity was investigated by stimulation of membrane preparations obtained from PROTEIN2 (beta-TC3)-, somatostatin (Rin 1027-B2)-, and glucagon (INR1-G9)-producing pancreatic cell lines using the non-hydrolyzable GTP analogue GTPgammaS alone, the C-terminal octapeptide cholecystokinin (CCK-8), or gastrin",IEPA.d171.s415
596,IEPA.d172,True,"Therefore, it was examined whether stimulation of Swiss 3T3 cells with PROTEIN1 causes changes in the subcellular distribution of EGF receptors and PROTEIN2 that could potentially explain the observed synergy or costimulation.",IEPA.d172.s416
597,IEPA.d172,False,"However, both EGF and PROTEIN stimulated the accumulation of PROTEIN1 at the actin arc, which was coincident with the EGF receptor in the case of PROTEIN2 stimulated cells.",IEPA.d172.s417
598,IEPA.d172,False,"However, both EGF and PROTEIN1 stimulated the accumulation of PROTEIN at the actin arc, which was coincident with the EGF receptor in the case of PROTEIN2 stimulated cells.",IEPA.d172.s417
599,IEPA.d172,True,"However, both EGF and PROTEIN1 stimulated the accumulation of PROTEIN2 at the actin arc, which was coincident with the EGF receptor in the case of PROTEIN stimulated cells.",IEPA.d172.s417
600,IEPA.d172,True,"Therefore, it is suggested that the PROTEIN1 induced coclustering of the EGF receptor with PROTEIN2 at the actin arc may allow for greater efficiency of signal transduction, resulting in the synergy observed for these two hormones in stimulation of DNA synthesis.",IEPA.d172.s418
601,IEPA.d173,False,We have established that the recovery of secreted PROTEIN1 is increased by the PROTEIN2 agonists PDBu and PMA in a time- and dose-dependent manner in both cell lines,IEPA.d173.s419
602,IEPA.d173,False,"In contrast, secretion of PROTEIN1 remains unaffected by the inactive PDBu analog alphaPDD and by the PROTEIN2 effectors dibutyryl cAMP and forskolin",IEPA.d173.s420
603,IEPA.d173,False,"Overall, our data indicate that the normal processing of PROTEIN is up-regulated by PROTEIN1 but not PROTEIN2 in human cells and murine neurons",IEPA.d173.s421
604,IEPA.d173,False,"Overall, our data indicate that the normal processing of PROTEIN1 is up-regulated by PROTEIN but not PROTEIN2 in human cells and murine neurons",IEPA.d173.s421
605,IEPA.d173,True,"Overall, our data indicate that the normal processing of PROTEIN1 is up-regulated by PROTEIN2 but not PROTEIN in human cells and murine neurons",IEPA.d173.s421
606,IEPA.d174,True,Dietary intakes of PROTEIN1 PROTEIN and PROTEIN by Japanese women and the inverse correlation between quercetin intake and plasma LDL PROTEIN2 concentration,IEPA.d174.s422
607,IEPA.d174,False,Dietary intakes of PROTEIN1 PROTEIN2 and PROTEIN by Japanese women and the inverse correlation between quercetin intake and plasma LDL PROTEIN concentration,IEPA.d174.s422
608,IEPA.d174,False,Dietary intakes of PROTEIN1 PROTEIN and PROTEIN2 by Japanese women and the inverse correlation between quercetin intake and plasma LDL PROTEIN concentration,IEPA.d174.s422
609,IEPA.d174,True,Dietary intakes of PROTEIN PROTEIN1 and PROTEIN by Japanese women and the inverse correlation between quercetin intake and plasma LDL PROTEIN2 concentration,IEPA.d174.s422
610,IEPA.d174,True,Dietary intakes of PROTEIN PROTEIN and PROTEIN1 by Japanese women and the inverse correlation between quercetin intake and plasma LDL PROTEIN2 concentration,IEPA.d174.s422
611,IEPA.d174,False,Dietary intakes of PROTEIN PROTEIN1 and PROTEIN2 by Japanese women and the inverse correlation between quercetin intake and plasma LDL PROTEIN concentration,IEPA.d174.s422
612,IEPA.d174,False,"The total intake of PROTEIN was inversely correlated with the plasma total PROTEIN1 concentration (TC) (r = -0.236, P: < 0.05) and plasma LDL PROTEIN2 concentration (LDL-C) (r = -0.220, P: < 0.05), after the adjustment for age, body mass index and total energy intake",IEPA.d174.s423
613,IEPA.d174,True,"The total intake of PROTEIN1 was inversely correlated with the plasma total PROTEIN2 concentration (TC) (r = -0.236, P: < 0.05) and plasma LDL PROTEIN concentration (LDL-C) (r = -0.220, P: < 0.05), after the adjustment for age, body mass index and total energy intake",IEPA.d174.s423
614,IEPA.d174,True,"The total intake of PROTEIN1 was inversely correlated with the plasma total PROTEIN concentration (TC) (r = -0.236, P: < 0.05) and plasma LDL PROTEIN2 concentration (LDL-C) (r = -0.220, P: < 0.05), after the adjustment for age, body mass index and total energy intake",IEPA.d174.s423
615,IEPA.d175,False,"Although the above data are consistent with a direct ability of PROTEIN1 to promote TRH biosynthesis through actions on TRH neurons, addition of a-MSH produced a 3.5 fold increase in TRH biosynthesis and release, whereas PROTEIN2 treatment suppressed ~3 fold proTRH biosynthesis",IEPA.d175.s424
616,IEPA.d176,True,"For example, PROTEIN1 suppresses PROTEIN2 (NPY) expression in the arcuate nucleus",IEPA.d176.s425
617,IEPA.d177,True,"As expected, in fusion of PROTEIN1 alone (18 microg/day) augmented food intake (191.6% over the initial control, P < 0.05) and produced a 25.1% weight gain in conjunction with a 10-fold increase in serum PROTEIN2 concentrations at the end of the 7-day period",IEPA.d177.s426
618,IEPA.d177,False,"Interestingly, coinfusion of this regimen of PROTEIN with the highly effective anorectic and body reducing effects of CNTF (5.0 microg/day) not only prevented the CNTF-induced anorexia and weight loss, but also normalized serum PROTEIN1 concentrations and hypothalamic PROTEIN2 gene expression",IEPA.d177.s427
619,IEPA.d177,True,"Interestingly, coinfusion of this regimen of PROTEIN1 with the highly effective anorectic and body reducing effects of CNTF (5.0 microg/day) not only prevented the CNTF-induced anorexia and weight loss, but also normalized serum PROTEIN2 concentrations and hypothalamic PROTEIN gene expression",IEPA.d177.s427
620,IEPA.d177,False,"Interestingly, coinfusion of this regimen of PROTEIN1 with the highly effective anorectic and body reducing effects of CNTF (5.0 microg/day) not only prevented the CNTF-induced anorexia and weight loss, but also normalized serum PROTEIN concentrations and hypothalamic PROTEIN2 gene expression",IEPA.d177.s427
621,IEPA.d177,False,"These results demonstrate that chronic central infusion to produce a persistent elevation of the cytokine at pathophysiological levels (a situation that may normally manifest during infection, injury and inflammation) produced severe anorexia and weight loss in conjunction with reduction in both serum PROTEIN1 concentrations and hypothalamic PROTEIN2 gene expression",IEPA.d177.s428
622,IEPA.d178,True,A caveolin-1-dependent coupling of PROTEIN1 to the PROTEIN2 was observed,IEPA.d178.s429
623,IEPA.d179,True,"Recently several significant advances have been made in this area, including the identification of the appetite regulating hormone, PROTEIN1 and a detailed understanding of its targets in the central nervous system (CNS), such as PROTEIN2 (NPY) and the melanocortin-4 receptor",IEPA.d179.s430
624,IEPA.d180,True,A loop system exists between hypothalamic PROTEIN1 (NPY) and peripheral adipose tissue PROTEIN2 to maintain normal body homeostasis,IEPA.d180.s431
625,IEPA.d180,True,"When infused i.c.v. to normal rats to mimic its central effects, PROTEIN1 decreases PROTEIN2 levels, thus food intake and body weight",IEPA.d180.s432
626,IEPA.d180,False,Circadian fluctuations of PROTEIN1 and PROTEIN2 levels maintain normal body homeostasis,IEPA.d180.s433
627,IEPA.d180,True," PROTEIN1 increases the expression of PROTEIN2 (UCP-1, -2, -3) and thus energy dissipation",IEPA.d180.s434
628,IEPA.d181,True,"Activity and expression of the three PROTEIN1 s are stimulated by several neuromediators and hormones such as noradrenaline, tri-iodothyronine and PROTEIN2 ",IEPA.d181.s435
629,IEPA.d182,True,"The effect of PROTEIN1 in adult rats appears to be exerted at hypothalamic level by regulating growth hormone releasing hormone (GHRH), somatostatin and PROTEIN2 (NPY)-producing neurones",IEPA.d182.s436
630,IEPA.d183,False,"Plasma insulin, cholecystokinin, galanin, PROTEIN1 and PROTEIN2 levels in obese women with and without type 2 diabetes mellitus",IEPA.d183.s437
631,IEPA.d183,False,"Experimental studies provided evidences that PROTEIN1 cholecystokinin (CCK), galanin (GAL), PROTEIN2 (NPY) and insulin are involved in feeding behaviour",IEPA.d183.s438
632,IEPA.d183,False,"Plasma concentrations of FSH, PROTEIN1 CCK, GAL, PROTEIN2 and insulin were determined using commercial RIA kits",IEPA.d183.s439
633,IEPA.d183,False,"Our results, ie higher mean plasma PROTEIN1 levels in postmenopausal diabetic women and positive correlation of CCK with PROTEIN2 and insulin, may suggest the role of these neuropeptides in metabolic disorders leading to type 2 diabetes mellitus",IEPA.d183.s440
634,IEPA.d184,False,These results suggest that T3 may increase PROTEIN1 family expression independent of PROTEIN2 action,IEPA.d184.s441
635,IEPA.d185,False,"The ARC PROTEIN1 neurones are stimulated by starvation, probably mediated by falls in circulating PROTEIN2 and insulin (which both inhibit these neurones), and contribute to the increased hunger in this and other conditions of energy deficit",IEPA.d185.s442
636,IEPA.d185,False,"ARC PROTEIN neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which PROTEIN1 inhibition is lost through mutations affecting PROTEIN2 or its receptor",IEPA.d185.s443
637,IEPA.d185,False,"ARC PROTEIN1 neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which PROTEIN2 inhibition is lost through mutations affecting PROTEIN or its receptor",IEPA.d185.s443
638,IEPA.d185,False,"ARC PROTEIN1 neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which PROTEIN inhibition is lost through mutations affecting PROTEIN2 or its receptor",IEPA.d185.s443
639,IEPA.d186,False," PROTEIN1 secretion, inositol phosphate levels, and PROTEIN2 isozymes in rodent pancreatic islets",IEPA.d186.s444
640,IEPA.d186,True,These findings are consistent with the concept that the underexpression of the nutrient-activated PROTEIN1 isozyme may account for the minimal inositol phosphate (IP) and second-phase PROTEIN2 secretory response from mouse islets,IEPA.d186.s445
641,IEPA.d187,True,Gibbestatin B inhibits the PROTEIN1 induced expression of PROTEIN2 expression in cereal seeds [In Process Citation],IEPA.d187.s446
642,IEPA.d187,True,The expression of PROTEIN1 in aleurone layers of barley is known to be induced by PROTEIN2 (GA).,IEPA.d187.s447
643,IEPA.d187,True,"In the present study, gibbestatin B (GNB) was isolated from Streptomyces sp. C-39 as an inhibitor of the PROTEIN1 induced expression of PROTEIN2 in barley and rice, with IC50 values of 125 and 70 microM, respectively.",IEPA.d187.s448
644,IEPA.d187,True,GNB suppressed accumulation of PROTEIN1 induced barley high-pI type B and rice RAmylA PROTEIN2 transcripts.,IEPA.d187.s449
645,IEPA.d187,True,"These analyses indicate that GNB inhibits the PROTEIN1 induced expression of PROTEIN2 by regulating one of the steps involved in ABA signaling, but not by acting as a weak ABA analog.",IEPA.d187.s450
646,IEPA.d188,True,"We also determined whether well known hypothalamic neuropeptide targets, e.g. PROTEIN1 (NPY), proopiomelanocortin (POMC), agouti-related peptide (AGRP) and cocaine and amphetamine-regulated transcript (CART) were regulated in a pattern consistent with their presumed roles as mediators of PROTEIN2 action",IEPA.d188.s451
647,IEPA.d188,True,"In contrast, PROTEIN1 decreased body weight and adiposity, increased CART and suppressed PROTEIN2 and AGRP mRNA expression in adult mice",IEPA.d188.s452
648,IEPA.d190,True, PROTEIN1 effects on pulsatile gonadotropin releasing hormone secretion from the adult rat hypothalamus and interaction with cocaine and amphetamine regulated transcript peptide and PROTEIN2 [In Process Citation],IEPA.d190.s454
649,IEPA.d190,True, PROTEIN1 may act as a negative feedback signal to the hypothalamic control of appetite through suppression of PROTEIN2 (NPY) secretion and stimulation of cocaine and amphetamine regulated transcript (CART).,IEPA.d190.s455
650,IEPA.d190,False,We aimed at studying the effects of PROTEIN1 CART and PROTEIN2 on the hypothalamic control of the pituitary-gonadal system.,IEPA.d190.s456
651,IEPA.d190,False,The increase in GnRH pulse amplitude caused by PROTEIN1 was totally prevented by coincubation with an anti-CART antiserum whereas it was not affected by coincubation with the PROTEIN2 Y5-receptor antagonist (10(-7) M).,IEPA.d190.s457
652,IEPA.d190,False,"In conclusion, PROTEIN1 and PROTEIN2 show separate permissive effects on GnRH secretion in the adult rat hypothalamus.",IEPA.d190.s458
653,IEPA.d191,True,"Similarly, central PROTEIN1 treatment also had a greater effect in suppressing hypothalamic PROTEIN2 mRNA expression in young (-23+/-4%) than in old (-8+/-4%) rats compared with their age-matched pair-fed treated rats",IEPA.d191.s459
654,IEPA.d192,True,"Compared with the wild type, PROTEIN1 induction of PROTEIN2 activity in aleurone cells of d1 was greatly reduced",IEPA.d192.s460
655,IEPA.d192,True,"Relative to the wild type, the PROTEIN1 3)-treated aleurone layer of d1 had lower expression of Ramy1A, which encodes PROTEIN2 and OsGAMYB, which encodes a PROTEIN inducible transcriptional factor, and no increase in expression of Ca(2 +)-ATPase",IEPA.d192.s461
656,IEPA.d192,False,"Relative to the wild type, the PROTEIN1 3)-treated aleurone layer of d1 had lower expression of Ramy1A, which encodes PROTEIN and OsGAMYB, which encodes a PROTEIN2 inducible transcriptional factor, and no increase in expression of Ca(2 +)-ATPase",IEPA.d192.s461
657,IEPA.d192,False,"Relative to the wild type, the PROTEIN 3)-treated aleurone layer of d1 had lower expression of Ramy1A, which encodes PROTEIN1 and OsGAMYB, which encodes a PROTEIN2 inducible transcriptional factor, and no increase in expression of Ca(2 +)-ATPase",IEPA.d192.s461
658,IEPA.d192,True,"However, in the presence of high PROTEIN1 concentrations, PROTEIN2 induction occurred even in d1",IEPA.d192.s462
659,IEPA.d192,True,"All these results suggest that d1 affects a part of the PROTEIN1 signaling pathway, namely the induction of PROTEIN2 in the aleurone layer and internode elongation",IEPA.d192.s463
660,IEPA.d193,False,"Finally, recent evidences suggest that melanocortins could be involved in mediating the effects of PROTEIN1 and in controlling the expression of PROTEIN2 (NPY)",IEPA.d193.s464
661,IEPA.d194,True, PROTEIN1 induced phospholipase D1 and phospholipase D2 activity in human embryonic kidney-293 cells mediated by the PROTEIN2 and protein kinase Calpha signalling cascade.,IEPA.d194.s465
662,IEPA.d194,False,"Co-expression of PLD1 with PROTEIN1 has the same effect, while co-expression of PLD2 with PROTEIN2 allows PLD2 activity to be stimulated in an PROTEIN dependent manner.",IEPA.d194.s466
663,IEPA.d194,False,"Co-expression of PLD1 with PROTEIN has the same effect, while co-expression of PLD2 with PROTEIN1 allows PLD2 activity to be stimulated in an PROTEIN2 dependent manner.",IEPA.d194.s466
664,IEPA.d194,False,"Co-expression of PLD1 with PROTEIN1 has the same effect, while co-expression of PLD2 with PROTEIN allows PLD2 activity to be stimulated in an PROTEIN2 dependent manner.",IEPA.d194.s466
665,IEPA.d194,False,"The PKC-specific inhibitors bisindolylmaleimide and Go 6976 abolish PROTEIN1 induced PLD2 activation in HEK-293 cells co-expressing the insulin receptor, PROTEIN2 and PLD2, confirming that not only PLD1, but PLD2 as well, is regulated in a PKC-dependent manner.",IEPA.d194.s467
666,IEPA.d194,True,"In summary, we demonstrate that PROTEIN1 treatment results in activation of both PLD1 and PLD2 in appropriate cell types when the appropriate upstream intermediate signalling components, i.e. PKCalpha and PROTEIN2 are expressed at sufficient levels.",IEPA.d194.s468
667,IEPA.d196,False,Both receive information about the nutritional status and the level of energy storage through insulin and PROTEIN1 signaling mediated by specific receptors located on POMC and PROTEIN2 neurons present predominantly in the arcuate nucleus (ARC).,IEPA.d196.s476
668,IEPA.d196,False,"When PROTEIN1 signaling is defective, through a defect in either the receptor (Zucker fa/fa rat, cp/cp rat, and db/db mouse) or in the peptide itself (ob/ob mouse), the PROTEIN2 system is upregulated as shown by mRNA overexpression and increased peptide release, whereas the content and/or release of some inhibitory peptides (neurotensin, cholecystokinin) are diminished.",IEPA.d196.s477
669,IEPA.d197,True, PROTEIN1 as a modulator of PROTEIN2 ,IEPA.d197.s478
670,IEPA.d197,True,"On the basis of far-Western blot and plasmon resonance (BIAcore) experiments, we show here that recombinant PROTEIN1 (bPrP) (25-242) strongly interacts with the catalytic alpha/alpha' subunits of PROTEIN2 (also termed 'casein kinase 2')",IEPA.d197.s479
671,IEPA.d197,False,We also show that PROTEIN1 counteracts the inhibition of calmodulin phosphorylation promoted by the regulatory beta subunits of PROTEIN2 ,IEPA.d197.s480
672,IEPA.d197,True,A truncated form of PROTEIN1 encompassing the C-terminal domain (residues 105-242) interacts with PROTEIN2 but does not affect its catalytic activity,IEPA.d197.s481
673,IEPA.d197,True,These results disclose the potential of the PROTEIN1 to modulate the activity of PROTEIN2 a pleiotropic PROTEIN that is particularly abundant in the brain,IEPA.d197.s482
674,IEPA.d197,False,These results disclose the potential of the PROTEIN1 to modulate the activity of PROTEIN a pleiotropic PROTEIN2 that is particularly abundant in the brain,IEPA.d197.s482
675,IEPA.d197,False,These results disclose the potential of the PROTEIN to modulate the activity of PROTEIN1 a pleiotropic PROTEIN2 that is particularly abundant in the brain,IEPA.d197.s482
676,IEPA.d198,True,"Arcuate nucleus PROTEIN1 mRNA increased in rats given protein-free diet, correlating with PROTEIN2 rather than decreased feeding",IEPA.d198.s483
677,IEPA.d199,True,The induction of PROTEIN1 triggered by PROTEIN2 in barley embryos is repressed by sugars,IEPA.d199.s484
678,IEPA.d199,False,"Our results indicate that glucose represses PROTEIN1 signalling late along this hormone transduction pathway, downstream of transcription of the PROTEIN modulated transcriptional activator (GAMYB) needed for PROTEIN2 induction",IEPA.d199.s485
679,IEPA.d199,False,"Our results indicate that glucose represses PROTEIN signalling late along this hormone transduction pathway, downstream of transcription of the PROTEIN1 modulated transcriptional activator (GAMYB) needed for PROTEIN2 induction",IEPA.d199.s485
680,IEPA.d199,False,"Our results indicate that glucose represses PROTEIN1 signalling late along this hormone transduction pathway, downstream of transcription of the PROTEIN2 modulated transcriptional activator (GAMYB) needed for PROTEIN induction",IEPA.d199.s485
